Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

Transporters influence the disposition of chemicals within the body by participating in absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) comprise a variety of proteins, including organic cation transporters (OCT) 1 to 3, organic cation/carnitine transporters (OCTN) 1 to 3, organic anion transporters (OAT) 1 to 7, various organic anion transporting polypeptide isoforms, sodium taurocholate cotransporting polypeptide, apical sodium-dependent bile acid transporter, peptide transporters (PEPT) 1 and 2, concentrative nucleoside transporters (CNT) 1 to 3, equilibrative nucleoside transporter (ENT) 1 to 3, and multidrug and toxin extrusion transporters (MATE) 1 and 2, which mediate the uptake (except MATEs) of organic anions and cations as well as peptides and nucleosides. Efflux transporters of the ATP-binding cassette superfamily, such as ATP-binding cassette transporter A1 (ABCA1), multidrug resistance proteins (MDR) 1 and 2, bile salt export pump, multidrug resistance-associated proteins (MRP) 1 to 9, breast cancer resistance protein, and ATP-binding cassette subfamily G members 5 and 8, are responsible for the unidirectional export of endogenous and exogenous substances. Other efflux transporters [ATPase copper-transporting β polypeptide (ATP7B) and ATPase class I type 8B member 1 (ATP8B1) as well as organic solute transporters (OST) α and β] also play major roles in the transport of some endogenous chemicals across biological membranes. This review article provides a comprehensive overview of these transporters (both rodent and human) with regard to tissue distribution, subcellular localization, and substrate preferences. Because uptake and efflux transporters are expressed in multiple cell types, the roles of transporters in a variety of tissues, including the liver, kidneys, intestine, brain, heart, placenta, mammary glands, immune cells, and testes are discussed. Attention is also placed upon a variety of regulatory factors that influence transporter expression and function, including transcriptional activation and post-translational modifications as well as subcellular trafficking. Sex differences, ontogeny, and pharmacological and toxicological regulation of transporters are also addressed. Transporters are important transmembrane proteins that mediate the cellular entry and exit of a wide range of substrates throughout the body and thereby play important roles in human physiology, pharmacology, pathology, and toxicology.

[1]  F. Kuipers,et al.  Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice. , 1998, Gastroenterology.

[2]  S. Wright,et al.  Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1. , 2001, The Journal of pharmacology and experimental therapeutics.

[3]  R. Angeletti,et al.  The choroid plexus epithelium is the site of the organic anion transport protein in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Y. Kokubo,et al.  A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. , 2004, Kidney international.

[5]  K. Kohno,et al.  Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. , 1998, Biochemical and biophysical research communications.

[6]  C. Paulusma,et al.  Intestinal bile salt absorption in Atp8b1 deficient mice. , 2007, Journal of hepatology.

[7]  B. Stieger,et al.  Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. , 1997, Journal of hepatology.

[8]  S. Masuda,et al.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[9]  P. Jansen,et al.  Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2018 .

[10]  D. Hipfner,et al.  Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. , 1997, Molecular pharmacology.

[11]  J. Nezu,et al.  Functional Characterization of Human Organic Anion Transporting Polypeptide B (OATP-B) in Comparison with Liver-Specific OATP-C , 2001, Pharmaceutical Research.

[12]  A. V. van Herwaarden,et al.  Sex-Dependent Expression and Activity of the ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (BCRP/ABCG2) in Liver , 2005, Molecular Pharmacology.

[13]  C. Klaassen,et al.  Postnatal expression and induction by pregnenolone-16alpha-carbonitrile of the organic anion-transporting polypeptide 2 in rat liver. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[14]  T. Abe,et al.  Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Mukhopadhyay,et al.  Genetic Polymorphisms in Human Proton-Dependent Dipeptide Transporter PEPT1: Implications for the Functional Role of Pro586 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[16]  U. Schumacher,et al.  Hyaluronan Export by the ABC Transporter MRP5 and Its Modulation by Intracellular cGMP* , 2007, Journal of Biological Chemistry.

[17]  P. Dawson,et al.  The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.

[18]  M. Kool,et al.  Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.

[19]  P. Kwok,et al.  Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2) , 2009, Journal of Pharmacology and Experimental Therapeutics.

[20]  D. Keppler,et al.  Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.

[21]  V. Catania,et al.  Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats , 2008, Drug Metabolism and Disposition.

[22]  R. Morris,et al.  ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE , 2006, Drug Metabolism and Disposition.

[23]  F. Suchy,et al.  Differential Developmental Regulation of Rat Liver Canalicular Membrane Transporters Bsep and Mrp2 , 2003, Pediatric Research.

[24]  Piet Borst,et al.  Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol , 2009, Molecular Pharmacology.

[25]  R. Kim,et al.  Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2 , 2002, Hepatology.

[26]  R. Ueda,et al.  ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. , 2009, Oncology reports.

[27]  M. Dean,et al.  The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  C. Boyd,et al.  Analysis of ABCC6 (MRP6) in normal human tissues , 2005, Histochemistry and Cell Biology.

[29]  M. Noda,et al.  Genetic variations of the ABC transporter gene ABCC3 in a Japanese population. , 2007, Drug metabolism and pharmacokinetics.

[30]  J. Uitto,et al.  Targeted ablation of Abcc1 or Abcc3 in Abcc6−/− mice does not modify the ectopic mineralization process , 2007, Experimental dermatology.

[31]  J. Schuetz,et al.  MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.

[32]  T. Uchihashi,et al.  Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. , 2007, International journal of oncology.

[33]  T. Horie,et al.  Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[34]  G. Koren,et al.  Ontogeny of Renal P-glycoprotein Expression in Mice: Correlation with Digoxin Renal Clearance , 2005, Pediatric Research.

[35]  K. Okumura,et al.  Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation , 2007, Hypertension.

[36]  S. Masuda,et al.  Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. , 2005, Drug metabolism and pharmacokinetics.

[37]  C. Klaassen,et al.  Regulation of hepatic transporters by xenobiotic receptors. , 2005, Current drug metabolism.

[38]  Zhe-Sheng Chen,et al.  Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). , 2002, Cancer research.

[39]  A. V. van Herwaarden,et al.  Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. , 2006, Carcinogenesis.

[40]  Y. Kikuchi,et al.  Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. , 2008, American journal of human genetics.

[41]  D. Keppler,et al.  Up‐regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver , 2001, Hepatology.

[42]  Y. Sugiyama,et al.  Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11 , 2005, Hepatology.

[43]  P. Bosma,et al.  Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver , 2000, Hepatology.

[44]  Fanfan Zhou,et al.  Comparison of the Interaction of Human Organic Anion Transporter hOAT4 with PDZ Proteins between Kidney Cells and Placental Cells , 2008, Pharmaceutical Research.

[45]  X. Xia,et al.  Degradation of the Apical Sodium-dependent Bile Acid Transporter by the Ubiquitin-Proteasome Pathway in Cholangiocytes* , 2004, Journal of Biological Chemistry.

[46]  H. Koepsell,et al.  Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. , 1998, Biochemical and biophysical research communications.

[47]  E. Boerwinkle,et al.  Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.

[48]  Thomas J. Raub,et al.  Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice , 2007, Drug Metabolism and Disposition.

[49]  Y. Kanai,et al.  Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.

[50]  R. Kim,et al.  Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.

[51]  V. Sasseville,et al.  A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.

[52]  F. O’Sullivan,et al.  Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate , 2009, Journal of Nuclear Medicine.

[53]  C. Trautwein,et al.  Hepatocyte nuclear factor-4 (cid:1) is a central transactivator of the mouse Ntcp gene , 2008 .

[54]  Oliver Fiehn,et al.  Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. , 2007, Physiological genomics.

[55]  Yusuke Nakamura,et al.  A SNP in the ABCC11 gene is the determinant of human earwax type , 2006, Nature Genetics.

[56]  A. Klein-Szanto,et al.  Analysis of the In Vivo Functions of Mrp3 , 2005, Molecular Pharmacology.

[57]  M. Vore,et al.  The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2) , 2005, Molecular Pharmacology.

[58]  P. A. Rea,et al.  Transport of amphipathic anions by human multidrug resistance protein 3. , 2000, Cancer research.

[59]  P. Meier,et al.  Functional expression of the canalicular bile salt export pump of human liver. , 2002, Gastroenterology.

[60]  H. Aburatani,et al.  ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. , 2002, Biochemical and biophysical research communications.

[61]  O. van Tellingen,et al.  Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo , 2009, Clinical Cancer Research.

[62]  M. Pastor-Anglada,et al.  Role of CNT3 in the transepithelial flux of nucleosides and nucleoside‐derived drugs , 2007, The Journal of physiology.

[63]  A. V. van Herwaarden,et al.  The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin , 2005, Molecular Pharmacology.

[64]  P. Dawson,et al.  The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis , 2008, Proceedings of the National Academy of Sciences.

[65]  H. Saito,et al.  Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. , 1995, The Journal of pharmacology and experimental therapeutics.

[66]  G. Burckhardt,et al.  Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. , 2005, American journal of physiology. Cell physiology.

[67]  L. Varticovski,et al.  Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells. , 2002, American journal of physiology. Cell physiology.

[68]  H. Endou,et al.  Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, The Journal of pharmacology and experimental therapeutics.

[69]  J. Mackey,et al.  Nucleoside transporters: molecular biology and implications for therapeutic development. , 1999, Molecular medicine today.

[70]  R. Ho,et al.  A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells. , 2006, Journal of pharmaceutical sciences.

[71]  D. Keppler,et al.  Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. , 2005, The Journal of urology.

[72]  P. Meier,et al.  Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. , 2001, Gastroenterology.

[73]  Yuichi Sugiyama,et al.  Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.

[74]  V. Ganapathy,et al.  Carnitine Content and Expression of Mitochondrial β-Oxidation Enzymes in Placentas of Wild-Type (OCTN2+/+) and OCTN2 Null (OCTN2−/−) Mice , 2004, Pediatric Research.

[75]  H. Yawo,et al.  Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1* , 1999, The Journal of Biological Chemistry.

[76]  C. Paulusma,et al.  The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease. , 2005, Biochimica et biophysica acta.

[77]  P. Dawson,et al.  Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. , 1994, The Journal of biological chemistry.

[78]  D. Keppler,et al.  Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). , 2002, European journal of biochemistry.

[79]  Y. Sugiyama,et al.  Characterization of inducible nature of MRP3 in rat liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[80]  P. Dawson,et al.  Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. , 1997, The Journal of clinical investigation.

[81]  J. Unadkat,et al.  FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N , 2005, Drug Metabolism and Disposition.

[82]  R. Kim,et al.  Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.

[83]  L. Doyle,et al.  A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[84]  S. Choudhuri,et al.  Gender-specific and developmental influences on the expression of rat organic anion transporters. , 2002, The Journal of pharmacology and experimental therapeutics.

[85]  N. Ballatori,et al.  Heterodimerization, trafficking and membrane topology of the two proteins, Ostα and Ostβ, that constitute the organic solute and steroid transporter , 2007 .

[86]  Y. Sugiyama,et al.  Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. , 2000, The Journal of pharmacology and experimental therapeutics.

[87]  Hassane Izzedine,et al.  Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. , 2006, The Journal of infectious diseases.

[88]  P. Dawson,et al.  Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice* , 2003, Journal of Biological Chemistry.

[89]  C. Klaassen Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. , 1974, The Journal of pharmacology and experimental therapeutics.

[90]  K. Toshimori,et al.  Expression and distribution of OCTN2 in mouse epididymis and its association with obstructive azoospermia in juvenile visceral steatosis mice , 2006, International journal of urology : official journal of the Japanese Urological Association.

[91]  R. Ho,et al.  MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. , 2006, Journal of pharmaceutical sciences.

[92]  B. Sarkadi,et al.  Loss of ATP-dependent Transport Activity in Pseudoxanthoma Elasticum-associated Mutants of Human ABCC6 (MRP6)* , 2002, The Journal of Biological Chemistry.

[93]  L. Gresh,et al.  Characterization of the Human OATP-C (SLC21A6) Gene Promoter and Regulation of Liver-specific OATP Genes by Hepatocyte Nuclear Factor 1α* , 2001, The Journal of Biological Chemistry.

[94]  D. Keppler,et al.  Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. , 2002, The Journal of urology.

[95]  T. Gilliam,et al.  Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. , 1999, Human molecular genetics.

[96]  Maristela L Onozato,et al.  Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. , 2004, European journal of pharmacology.

[97]  Ning Li,et al.  Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4. , 2002, The Journal of pharmacology and experimental therapeutics.

[98]  S. Masuda,et al.  Molecular Cloning, Functional Characterization and Tissue Distribution of Rat H+/Organic Cation Antiporter MATE1 , 2006, Pharmaceutical Research.

[99]  S. Cisternino,et al.  Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. , 2004, Cancer research.

[100]  S. Scherer,et al.  A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). , 2003, Biochemical and biophysical research communications.

[101]  J. Kim,et al.  Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. , 2000, The Biochemical journal.

[102]  C. Klaassen Immaturity of the newborn rat's hepatic excretory function for ouabain. , 1972, The Journal of pharmacology and experimental therapeutics.

[103]  Y. Cheung,et al.  MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese , 2004, Journal of Medical Genetics.

[104]  T. Welte,et al.  Expression, Localisation and Functional Implications of the Transporter Protein PEPT2 in the Upper Respiratory Tract , 2008, Respiration.

[105]  Yoshiro Saito,et al.  Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). , 2004, Drug metabolism and pharmacokinetics.

[106]  J. Schellens,et al.  Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1−/−/Mdr1a/1b−/− (triple-knockout) and wild-type mice , 2008, Molecular Cancer Therapeutics.

[107]  R. O. Oude Elferink,et al.  Increased serum concentrations of secondary bile salts during cholate feeding are due to coprophagy. A study with wild-type and Atp8b1-deficient mice. , 2006, Molecular pharmaceutics.

[108]  Y. Kato,et al.  PDZ Adaptor Protein PDZK2 Stimulates Transport Activity of Organic Cation/Carnitine Transporter OCTN2 by Modulating Cell Surface Expression , 2006, Drug Metabolism and Disposition.

[109]  R. Vonk,et al.  Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. , 2000, Gastroenterology.

[110]  W. Hait,et al.  Regulation of the Stability of P-Glycoprotein by Ubiquitination , 2004, Molecular Pharmacology.

[111]  A. Andriulli,et al.  Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. , 2006, World journal of gastroenterology.

[112]  P. García-Miranda,et al.  Developmental Maturation and Segmental Distribution of Rat Small Intestinal L-Carnitine Uptake , 2005, The Journal of Membrane Biology.

[113]  J. Brouwers,et al.  Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo. , 2009, Gastroenterology.

[114]  Dieter Schrenk,et al.  Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution , 2001, Journal of Human Genetics.

[115]  Y. Sugiyama,et al.  Short-Chain Ubiquitination Is Associated with the Degradation Rate of a Cell-Surface-Resident Bile Salt Export Pump (BSEP/ABCB11) , 2009, Molecular Pharmacology.

[116]  David S. Miller,et al.  Functional expression of renal organic anion transport in Xenopus laevis oocytes , 1992, Molecular and Cellular Biochemistry.

[117]  K. Chiba,et al.  A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy. , 2004, Drug metabolism and pharmacokinetics.

[118]  D. Keppler,et al.  The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. , 1997, Advances in enzyme regulation.

[119]  J. Testa,et al.  Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. , 2001, Cancer letters.

[120]  N. Longo,et al.  Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[121]  M. Hediger,et al.  Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. , 1995, Biochimica et biophysica acta.

[122]  P. Meier,et al.  Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. , 2002, The Journal of clinical endocrinology and metabolism.

[123]  I. Lerer,et al.  The H syndrome is caused by mutations in the nucleoside transporter hENT3. , 2008, American journal of human genetics.

[124]  Jos H Beijnen,et al.  P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan , 2007, Clinical Cancer Research.

[125]  F. Kuipers,et al.  Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. , 2001, The Journal of clinical investigation.

[126]  M. Hediger,et al.  Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.

[127]  Y. Sugiyama,et al.  Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[128]  D. Moore,et al.  trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors , 2006, Molecular Pharmacology.

[129]  G. Peters,et al.  The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. , 2005, Cancer research.

[130]  H. Daniel,et al.  The Peptide Transporter PEPT2 is Targeted by the Protein Kinase SGK1 and the Scaffold Protein NHERF2 , 2008, Cellular Physiology and Biochemistry.

[131]  Thomas J. Jones,et al.  Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice , 2005, Hepatology.

[132]  Richard J. Thompson,et al.  Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. , 2008, Gastroenterology.

[133]  Jos H. Beijnen,et al.  Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment , 2009, Clinical Cancer Research.

[134]  K. Faber,et al.  LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[135]  Y. Kanai,et al.  The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. , 1999, The Journal of pharmacology and experimental therapeutics.

[136]  B. Dallapiccola,et al.  Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. , 2006, Inflammatory bowel diseases.

[137]  I. Roninson,et al.  Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. , 1995, Biochemistry.

[138]  P. Swaan,et al.  Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains. , 2006, Biochemistry.

[139]  S. Yao,et al.  Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). , 1997, The American journal of physiology.

[140]  R. Keep,et al.  Impact of Genetic Knockout of PEPT2 on Cefadroxil Pharmacokinetics, Renal Tubular Reabsorption, and Brain Penetration in Mice , 2007, Drug Metabolism and Disposition.

[141]  J. C. Baayen,et al.  Localization of Breast Cancer Resistance Protein (BCRP) in Microvessel Endothelium of Human Control and Epileptic Brain , 2005, Epilepsia.

[142]  C. Gartung,et al.  Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis , 2003, Hepatology.

[143]  J. Schuetz,et al.  The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.

[144]  J. Glavy,et al.  Down-regulation by Extracellular ATP of Rat Hepatocyte Organic Anion Transport Is Mediated by Serine Phosphorylation of Oatp1* , 2000, The Journal of Biological Chemistry.

[145]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[146]  K. Motojima,et al.  PPARα Agonists Positively and Negatively Regulate the Expression of Several Nutrient/Drug Transporters in Mouse Small Intestine , 2007 .

[147]  H. Tilg,et al.  Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[148]  R. Kerwin,et al.  The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice , 2007, Neuropsychopharmacology.

[149]  B. Thorens,et al.  Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy , 2009, Proceedings of the National Academy of Sciences.

[150]  T. Ishikawa,et al.  Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. , 2007, The Biochemical journal.

[151]  Q. Garrett,et al.  Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. , 2008, Investigative ophthalmology & visual science.

[152]  H. Takanaga,et al.  Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells , 2004, Journal of neurochemistry.

[153]  A. Jaiswal,et al.  Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[154]  M. Komada,et al.  Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. , 2008, The Biochemical journal.

[155]  T. Dale,et al.  The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk , 2005, Nature Medicine.

[156]  N. Ballatori,et al.  N-glycosylation controls functional activity of Oatp1, an organic anion transporter. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[157]  C. Tse,et al.  Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[158]  K. Itoh,et al.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. , 2003, The Biochemical journal.

[159]  F. Lang,et al.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.

[160]  T. Pusl,et al.  Intrahepatic cholestasis of pregnancy , 2007, Orphanet journal of rare diseases.

[161]  J. Boyer,et al.  Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies. , 1994, The American journal of physiology.

[162]  R. Balling,et al.  Targeted Disruption of the Peptide Transporter Pept2 Gene in Mice Defines Its Physiological Role in the Kidney , 2003, Molecular and Cellular Biology.

[163]  Osamu Ogawa,et al.  Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. , 2007, Biochemical pharmacology.

[164]  H. Kusuhara,et al.  Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta. , 2008, The Journal of pharmacology and experimental therapeutics.

[165]  H. Koepsell,et al.  Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.

[166]  Piet Borst,et al.  MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.

[167]  S. Yao,et al.  Molecular Cloning and Functional Characterization of Nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) Equilibrative Nucleoside Transporter Proteins (rENT1 and rENT2) from Rat Tissues* , 1997, The Journal of Biological Chemistry.

[168]  T. Ohtsubo,et al.  Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood–inner ear barrier in mice , 2000, Brain Research.

[169]  B. Sarkadi,et al.  C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. , 2003, Biochemical and biophysical research communications.

[170]  N. Longo,et al.  Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy , 2004, Journal of Inherited Metabolic Disease.

[171]  Jonathan C. Cohen,et al.  Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8 Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500124-JLR200 , 2005, Journal of Lipid Research.

[172]  J. Beijnen,et al.  Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides , 2007, Molecular Pharmacology.

[173]  A. Groen,et al.  The role of mdr2 P‐glycoprotein in hepatobiliary lipid transport , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[174]  N. Nabulsi,et al.  [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. , 2005, Bioorganic & medicinal chemistry.

[175]  V. Catania,et al.  Shift from Biliary to Urinary Elimination of Acetaminophen-Glucuronide in Acetaminophen-Pretreated Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[176]  P. Gros,et al.  Structural and functional characterization of the mouse multidrug resistance gene family. , 1990, Bulletin du cancer.

[177]  J. Peters,et al.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[178]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[179]  Y. Kanai,et al.  Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. , 1999, Molecular pharmacology.

[180]  V. Ganapathy,et al.  Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. , 2000, American journal of physiology. Renal physiology.

[181]  T. Merriman,et al.  Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort , 2006, Immunology and cell biology.

[182]  Alfred H. Schinkel,et al.  BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) TRANSPORTS FLUOROQUINOLONE ANTIBIOTICS AND AFFECTS THEIR ORAL AVAILABILITY, PHARMACOKINETICS, AND MILK SECRETION , 2006, Drug Metabolism and Disposition.

[183]  E. Burchard,et al.  Effects of Genetic Variation in the Novel Organic Cation Transporter, OCTN1, on the Renal Clearance of Gabapentin , 2008, Clinical pharmacology and therapeutics.

[184]  S. Nielsen,et al.  ATP7B copper-regulated traffic and association with the tight junctions: copper excretion into the bile. , 2008, Gastroenterology.

[185]  R. Keep,et al.  Peptide transporter 2 (PEPT2) expression in brain protects against 5‐aminolevulinic acid neurotoxicity , 2007, Journal of neurochemistry.

[186]  A. Latiano,et al.  Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. , 2007, World journal of gastroenterology.

[187]  D. H. Sweet,et al.  Expression Cloning and Characterization of ROAT1 , 1997, The Journal of Biological Chemistry.

[188]  M. Niemi,et al.  Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin , 2006, Pharmacogenetics and genomics.

[189]  C. Beglinger,et al.  Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. , 2005, Biochemical pharmacology.

[190]  Steffen Bauer,et al.  Evidence for Inverse Effects of OATP‐C (SLC21A6) *5 and *1b Haplotypes on Pravastatin Kinetics , 2004, Clinical pharmacology and therapeutics.

[191]  T. Terasaki,et al.  Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine , 2009, Journal of Pharmacology and Experimental Therapeutics.

[192]  D. Hipfner,et al.  Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[193]  C. Klaassen,et al.  Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. , 2008, Toxicology and applied pharmacology.

[194]  D. Rosskopf,et al.  Uptake of Cardiovascular Drugs Into the Human Heart: Expression, Regulation, and Function of the Carnitine Transporter OCTN2 (SLC22A5) , 2006, Circulation.

[195]  T. Kamisako,et al.  Alteration of the expression of adenosine triphosphate‐binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis , 2005, Journal of gastroenterology and hepatology.

[196]  Physiology, structure, and regulation of the cloned organic anion transporters. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[197]  I. Arias,et al.  Mdr 2 Knockout mice link biliary phospholipid deficiency with small bile duct destruction , 1994, Hepatology.

[198]  I. Song,et al.  Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[199]  C. Gui,et al.  Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[200]  K. Inui,et al.  Hepatocyte nuclear factor-4 regulates the human organic anion transporter 1 gene in the kidney , 2007 .

[201]  K. Peng,et al.  Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[202]  C. Klaassen,et al.  Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[203]  A. Enomoto,et al.  Novel liver‐specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate , 2007, Hepatology.

[204]  P. Dawson,et al.  Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. , 1996, The American journal of physiology.

[205]  中島 典子 Developmental Changes in Multispecific Organic Anion Transporter 1 (OAT1)Expression in the Rat Kidney , 2000 .

[206]  J. Boyer,et al.  Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.

[207]  K. Lesch,et al.  Decreased anxiety in mice lacking the organic cation transporter 3 , 2009, Journal of Neural Transmission.

[208]  C. Eaves,et al.  Liver and marrow of adult mdr-1a/1b(-/-) mice show normal generation, function, and multi-tissue trafficking of primitive hematopoietic cells. , 2002, Experimental hematology.

[209]  J. Shim,et al.  Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population , 2007, Drug Metabolism and Disposition.

[210]  S. Thorgeirsson,et al.  Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication , 1993, Hepatology.

[211]  P. Meier,et al.  Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[212]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[213]  M. Piquette-Miller,et al.  Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia , 2002, Journal of Pharmacology and Experimental Therapeutics.

[214]  K. Nagasawa,et al.  Mouse equilibrative nucleoside transporter 2 (mENT2) transports nucleosides and purine nucleobases differing from human and rat ENT2. , 2007, Biological & pharmaceutical bulletin.

[215]  J. Boyer,et al.  Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. , 2000, Gastroenterology.

[216]  Y. Sugiyama,et al.  Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. , 1997, Cancer research.

[217]  M. Oshimura,et al.  FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.

[218]  Mi-Hye Lee,et al.  Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. , 2002, Journal of lipid research.

[219]  Y. Kanai,et al.  Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. , 1999, Journal of the American Society of Nephrology : JASN.

[220]  L. Lue,et al.  ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.

[221]  F. Suchy,et al.  Sorting of rat liver and ileal sodium-dependent bile acid transporters in polarized epithelial cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[222]  P. Meier,et al.  Characterization of the mouse bile salt export pump overexpressed in the baculovirus system , 2001, Hepatology.

[223]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[224]  R. Kim,et al.  Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. , 2000, Molecular pharmacology.

[225]  R. Burk,et al.  Immunologic distribution of an organic anion transport protein in rat liver and kidney. , 1996, The American journal of physiology.

[226]  S. DeKosky,et al.  Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease , 2007, Neurobiology of Aging.

[227]  S. Nyström,et al.  Ontogenetic Development and Spatial Distribution of the Ileal Apical Sodium-Dependent Bile Acid Transporter and the Ileal Lipid-Binding Protein in ApoE Knockout and C57BL/6 Mice , 2002, Scandinavian journal of gastroenterology.

[228]  W. Fung-Leung,et al.  ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.

[229]  Y. Sugiyama,et al.  Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[230]  T. Miloh,et al.  beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[231]  C. Klaassen,et al.  Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. , 2006, Life sciences.

[232]  H. Kotani,et al.  Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 , 2004, International journal of cancer.

[233]  T. Ludwig,et al.  Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. , 2005, The American journal of pathology.

[234]  Paul B Watkins,et al.  Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity , 2007, Journal of Pharmacology and Experimental Therapeutics.

[235]  G R Lankas,et al.  Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.

[236]  P. Jansen,et al.  Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. , 1989, The Journal of clinical investigation.

[237]  R. Davey,et al.  The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. , 1996, British Journal of Cancer.

[238]  Conrad C. Huang,et al.  The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. , 2006, American journal of physiology. Renal physiology.

[239]  N. Ballatori,et al.  Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter. , 2007, The Biochemical journal.

[240]  N. Freimer,et al.  A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. , 2004, Human molecular genetics.

[241]  P. Olinga,et al.  Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[242]  D. Häussinger,et al.  De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: A novel mechanism of cholestasis , 2009, Hepatology.

[243]  Xingguo Cheng,et al.  Tissue Distribution, Gender-Divergent Expression, Ontogeny, and Chemical Induction of Multidrug Resistance Transporter Genes (Mdr1a, Mdr1b, Mdr2) in Mice , 2009, Drug Metabolism and Disposition.

[244]  T. Thalhammer,et al.  Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium , 2004, Laboratory Investigation.

[245]  J. Schuetz,et al.  Multidrug-resistance-associated protein 1 (Mrp1) is probably not required for murine Th cell activation. , 2006, International immunology.

[246]  J. Kim,et al.  Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.

[247]  Sarfaraz Ahmad,et al.  Transport of N-Acetylcysteine S-Conjugates of Methylmercury in Madin-Darby Canine Kidney Cells Stably Transfected with Human Isoform of Organic Anion Transporter 1 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[248]  Kaoru Kobayashi,et al.  Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells , 2005, Pharmacogenetics and genomics.

[249]  T. Cihlar,et al.  The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.

[250]  I. Catalá,et al.  Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material , 2002, The Journal of pathology.

[251]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[252]  Liqi Lai,et al.  Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. , 2002, The Biochemical journal.

[253]  J. Nezu,et al.  Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa. , 2007, Reproduction.

[254]  Supratim Choudhuri,et al.  Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[255]  Min Goo Lee,et al.  MRP2 haplotypes confer differential susceptibility to toxic liver injury , 2007, Pharmacogenetics and genomics.

[256]  C. Stanley,et al.  Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. , 2002, Molecular genetics and metabolism.

[257]  J. Schellens,et al.  The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. , 2005, Cancer research.

[258]  D. Groneberg,et al.  Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. , 2001, The American journal of pathology.

[259]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[260]  Y. Kanai,et al.  Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. , 2004, Biochemical and biophysical research communications.

[261]  B. Müller-Myhsok,et al.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn’s disease , 2005, Gut.

[262]  J. Boyer,et al.  Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[263]  C. Klaassen,et al.  TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE , 2004, Drug Metabolism and Disposition.

[264]  I. Arias,et al.  Transporters on Demand: Intracellular Reservoirs and Cycling of Bile Canalicular ABC Transporters* , 2006, Journal of Biological Chemistry.

[265]  V. Ling,et al.  Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.

[266]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[267]  Thomas J. Raub,et al.  Roles of P-Glycoprotein, Bcrp, and Mrp2 in Biliary Excretion of Spiramycin in Mice , 2007, Antimicrobial Agents and Chemotherapy.

[268]  I. Coe,et al.  Differential expression of human nucleoside transporters in normal and tumor tissue. , 2001, Biochemical and biophysical research communications.

[269]  I. Kema,et al.  Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. , 2004, Gastroenterology.

[270]  M. Orth,et al.  SEVERE TANGIER DISEASE WITH A NOVEL ABCA1 GENE MUTATION , 2008, Neurology.

[271]  A. Sparreboom,et al.  Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin‐Induced Nephrotoxicity , 2009, Clinical pharmacology and therapeutics.

[272]  S. Nigam,et al.  Molecular Cloning and Characterization of NKT, a Gene Product Related to the Organic Cation Transporter Family That Is Almost Exclusively Expressed in the Kidney* , 1997, The Journal of Biological Chemistry.

[273]  N. Ballatori,et al.  Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. , 2001, Molecular pharmacology.

[274]  C. Webster,et al.  Role of Protein Phosphatases in Cyclic AMP-mediated Stimulation of Hepatic Na+/Taurocholate Cotransport* , 1998, The Journal of Biological Chemistry.

[275]  H. Rosing,et al.  Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk , 2006, Molecular and Cellular Biology.

[276]  P. Neuvonen,et al.  Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics , 2006, Pharmacogenetics and genomics.

[277]  Braxton D Mitchell,et al.  Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. , 2008, Arthritis and rheumatism.

[278]  J. Martinez-Picado,et al.  Interaction of Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with the Concentrative Nucleoside Transporter-1 (Slc28A1) , 2004, Antiviral therapy.

[279]  G. L. Youngblood,et al.  Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). , 2006, American journal of physiology. Renal physiology.

[280]  C Roland Wolf,et al.  Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2. , 2005, Biochemical pharmacology.

[281]  T. Nakanishi,et al.  Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. , 2004, Molecular pharmaceutics.

[282]  M. Eichelbaum,et al.  Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. , 2002, Pharmacogenetics.

[283]  Hideyuki Saito,et al.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[284]  M. Dean The genetics of ATP-binding cassette transporters. , 2005, Methods in enzymology.

[285]  R. Keep,et al.  PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes , 2006, Brain Research.

[286]  R. Roberts,et al.  Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition* , 2004, Journal of Biological Chemistry.

[287]  C. Sensen,et al.  Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux , 1999, The Lancet.

[288]  S. Sookoian,et al.  Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. , 2008, Journal of hepatology.

[289]  G. Folkers,et al.  Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. , 2002, Molecular endocrinology.

[290]  Yusuke Nakamura,et al.  Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel‐induced leukopenia , 2008, Cancer science.

[291]  K. Inui,et al.  Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney. , 2007, American journal of physiology. Renal physiology.

[292]  T. Litman,et al.  Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.

[293]  H. Koepsell,et al.  Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. , 2005, Journal of the American Society of Nephrology : JASN.

[294]  N. Ballatori,et al.  Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[295]  K. Ueda,et al.  The COP9 signalosome controls ubiquitinylation of ABCA1. , 2009, Biochemical and biophysical research communications.

[296]  T. van der Poll,et al.  Mice Lacking the Multidrug Resistance Protein 1 Are Resistant to Streptococcus pneumoniae-Induced Pneumonia1 , 2001, The Journal of Immunology.

[297]  T. van der Velde-Koerts,et al.  Structure of the human MDR3 gene and physical mapping of the human MDR locus. , 1991, The Journal of biological chemistry.

[298]  J. Schellens,et al.  Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[299]  G. Aithal,et al.  Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. , 2007, Gastroenterology.

[300]  R. Angeletti,et al.  Rat organic anion transporting protein 1A1 (Oatp1a1): purification and phosphopeptide assignment. , 2006, Biochemistry.

[301]  R. Evans,et al.  Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[302]  P. Duan,et al.  Regulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha. , 2009, American journal of physiology. Endocrinology and metabolism.

[303]  M. Rex-Haffner,et al.  Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[304]  W. Sadee,et al.  Genetic Variants of the Human H+/Dipeptide Transporter PEPT2: Analysis of Haplotype Functions , 2004, Journal of Pharmacology and Experimental Therapeutics.

[305]  R. Collins,et al.  SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.

[306]  I. Diamond,et al.  Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene. , 2000, Biochemical and biophysical research communications.

[307]  Y. Kanai,et al.  Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, American journal of physiology. Renal physiology.

[308]  V. Vallon,et al.  Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. , 2008, American journal of physiology. Renal physiology.

[309]  C. Cass,et al.  Distribution of Equilibrative, Nitrobenzylthioinosine‐Sensitive Nucleoside Transporters (ENT1) in Brain , 1999, Journal of neurochemistry.

[310]  K. Zatloukal,et al.  Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.

[311]  J. Knoll,et al.  PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[312]  H. Koepsell,et al.  The SLC22 drug transporter family , 2004, Pflügers Archiv.

[313]  P. Meier,et al.  Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3 , 2001, Pflügers Archiv.

[314]  J. Itoh,et al.  Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[315]  V. Ganapathy,et al.  Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.

[316]  Curtis D. Klaassen,et al.  INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.

[317]  H. Tomita,et al.  Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[318]  A. Wanner,et al.  The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. , 2007, The Journal of allergy and clinical immunology.

[319]  R. Kanamoto,et al.  Characterization of Cloned Mouse Na+/taurocholate Cotransporting Polypeptide by Transient Expression in COS-7 Cells , 2002, Bioscience, biotechnology, and biochemistry.

[320]  S. Cole,et al.  Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells. , 2009, Biochemical and biophysical research communications.

[321]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[322]  H. Daniel,et al.  H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[323]  X. Chu,et al.  Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) , 2006, Journal of Pharmacology and Experimental Therapeutics.

[324]  H. Kusuhara,et al.  Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. , 2006, Molecular pharmacology.

[325]  Jos H. Beijnen,et al.  Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein , 1997, Nature Medicine.

[326]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[327]  Yuichi Sugiyama,et al.  Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens , 2007, Molecular Pharmacology.

[328]  I. Pastan,et al.  MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer , 2001, Molecular medicine.

[329]  Zhe-Sheng Chen,et al.  Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.

[330]  D. Keppler,et al.  Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system , 2006, Neuroscience.

[331]  G. Rappold,et al.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.

[332]  A. Aguzzi,et al.  Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. , 2000, The Journal of pharmacology and experimental therapeutics.

[333]  S. Bornstein,et al.  Molecular evidence of organic ion transporters in the rat adrenal cortex with adrenocorticotropin-regulated zonal expression. , 2003, Endocrinology.

[334]  Adriana M. Torres,et al.  Sex differences in p-aminohippuric acid transport in rat kidney: Role of membrane fluidity and expression of OAT1 , 2002, Molecular and Cellular Biochemistry.

[335]  Dean P. Jones,et al.  Role of the Multidrug Resistance Protein-1 in Hypertension and Vascular Dysfunction Caused by Angiotensin II , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[336]  K. Zatloukal,et al.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.

[337]  T. Ishikawa,et al.  MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[338]  Rachel M. Bailey,et al.  Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. , 2007, American journal of physiology. Renal physiology.

[339]  J. Petrick,et al.  Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport , 2007, Drug Metabolism and Disposition.

[340]  T. Ishikawa,et al.  Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system. , 2006, Journal of experimental therapeutics & oncology.

[341]  A. Groen,et al.  The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. , 1997, Journal of hepatology.

[342]  Honggang Wang,et al.  The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study , 2007, Molecular Pharmacology.

[343]  A. M. van der Bliek,et al.  Sequence of mdr3 cDNA encoding a human P-glycoprotein. , 1988, Gene.

[344]  V. Ganapathy,et al.  Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. , 1997, Biochimica et biophysica acta.

[345]  Guorong Xu,et al.  Faculty Opinions recommendation of The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. , 2008 .

[346]  Yuichi Sugiyama,et al.  Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin , 2002, Journal of Pharmacology and Experimental Therapeutics.

[347]  A. Enomoto,et al.  Functional Characterization of Rat Organic Anion Transporter 5 (Slc22a19) at the Apical Membrane of Renal Proximal Tubules , 2005, Journal of Pharmacology and Experimental Therapeutics.

[348]  Xingguo Cheng,et al.  Endocrine Regulation of Gender-Divergent Mouse Organic Anion-Transporting Polypeptide (Oatp) Expression , 2006, Molecular Pharmacology.

[349]  H. Kusuhara,et al.  Regulation of Tissue-Specific Expression of the Human and Mouse Urate Transporter 1 Gene by Hepatocyte Nuclear Factor 1 α/β and DNA Methylation , 2007, Molecular Pharmacology.

[350]  N. Maeda,et al.  A mouse model of sitosterolemia : absence of Abcg 8 / sterolin-2 results in failure to secrete biliary cholesterol , 2004 .

[351]  Yusuke Nakamura,et al.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.

[352]  D. Keppler,et al.  Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. , 2008, Expert opinion on drug metabolism & toxicology.

[353]  P. Dawson,et al.  The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. , 2005, The Journal of biological chemistry.

[354]  B. Stieger,et al.  Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil , 2007, Drug Metabolism and Disposition.

[355]  Richard J. Thompson,et al.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.

[356]  S. Tsuchida,et al.  Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1 , 2004, Transplantation.

[357]  S. Strom,et al.  ATPase Class I Type 8B Member 1 and Protein Kinase C ζ Induce the Expression of the Canalicular Bile Salt Export Pump in Human Hepatocytes , 2010, Pediatric Research.

[358]  M. Sheng,et al.  PDZ Domains: Structural Modules for Protein Complex Assembly* , 2002, The Journal of Biological Chemistry.

[359]  J. Nezu,et al.  Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[360]  D. Barlow,et al.  Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.

[361]  S. Ferdinandusse,et al.  PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. , 2007, Biochimica et biophysica acta.

[362]  R. Evers,et al.  Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 , 1997, FEBS letters.

[363]  Y. Sugiyama,et al.  Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[364]  P. Acott,et al.  BRAIN CYCLOSPORIN A LEVELS ARE DETERMINED BY ONTOGENIC REGULATION OF MDR1A EXPRESSION , 2006, Drug Metabolism and Disposition.

[365]  D. Häussinger,et al.  Inborn errors of biliary canalicular transport systems. , 2005, Methods in enzymology.

[366]  C. Gau,et al.  Interaction between Anticonvulsants and Human Placental Carnitine Transporter , 2004, Epilepsia.

[367]  D. Butterfield,et al.  Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin , 2009, Molecular Pharmacology.

[368]  N. Ballatori,et al.  Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. , 2000, Molecular pharmacology.

[369]  K. Faber,et al.  Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump , 2002, Hepatology.

[370]  J. Schellens,et al.  The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib , 2009, Investigational New Drugs.

[371]  P. Meier,et al.  Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[372]  J. Willoughby,et al.  PHYSIOLOGIC SECRETION OF GROWTH HORMONE AND PROLACTIN IN MALE AND FEMALE RATS , 1977, Clinical endocrinology.

[373]  P. Dawson,et al.  OSTα‐OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia , 2005 .

[374]  N. Longo,et al.  Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype–phenotype correlation , 2000, Human mutation.

[375]  J. Wijnholds,et al.  Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. , 2002, Molecular pharmacology.

[376]  M. Trauner,et al.  Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[377]  T. Okada,et al.  Experimental LPS‐induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: A quantitative colocalization study , 2005, Microscopy research and technique.

[378]  T. Sugiyama,et al.  Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, OCTN2. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[379]  R. Kerwin,et al.  Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters , 2001, British journal of pharmacology.

[380]  Richard J. Thompson,et al.  Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy , 2008, Gut.

[381]  Y. Sugiyama,et al.  Transfected Rat cMOAT Is Functionally Expressed on the Apical Membrane in Madin-Darby Canine Kidney (MDCK) Cells , 1998, Pharmaceutical Research.

[382]  Joanne Wang,et al.  Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. , 2007, American journal of physiology. Renal physiology.

[383]  S. Cole,et al.  Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1) , 2005, Pharmacogenetics and genomics.

[384]  J. Miquel,et al.  Localization of the Sodium-Taurocholate cotransporting polypeptide in membrane rafts and modulation of its activity by cholesterol in vitro. , 2008, Biochimica et biophysica acta.

[385]  S. Kliewer,et al.  Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. , 2002, Molecular pharmacology.

[386]  P. Meier,et al.  Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. , 2008, World journal of gastroenterology.

[387]  Fanfan Zhou,et al.  Role of Glycosylation in the Organic Anion Transporter OAT1* , 2004, Journal of Biological Chemistry.

[388]  D. Keppler,et al.  Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). , 2004, Pharmacogenetics.

[389]  I Meineke,et al.  The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin , 2009, Clinical pharmacology and therapeutics.

[390]  N. Ballatori,et al.  Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[391]  Jonathan C. Cohen,et al.  Selective sterol accumulation in ABCG5/ABCG8-deficient mice Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300377-JLR200 , 2004, Journal of Lipid Research.

[392]  L. Mangravite,et al.  Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. , 2003, American journal of physiology. Renal physiology.

[393]  J. Boyer,et al.  Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. , 2001, Gastroenterology.

[394]  R. Keep,et al.  Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[395]  G. Scheffer,et al.  Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases , 2007, Drug Metabolism and Disposition.

[396]  P. Dawson,et al.  Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.

[397]  M. Kool,et al.  Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. , 2000, Cancer research.

[398]  Joseph W. Polli,et al.  An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016) , 2009, Drug Metabolism and Disposition.

[399]  Praveen M. Bahadduri,et al.  Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. , 2005, American journal of respiratory cell and molecular biology.

[400]  T. Hasegawa,et al.  Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice , 2005, Neuroscience Letters.

[401]  Y. Kanai,et al.  Posttranslational regulation of Abcc2 expression by SUMOylation system. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[402]  I. Hyodo,et al.  Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[403]  Y. Sugiyama,et al.  4‐phenylbutyrate enhances the cell surface expression and the transport capacity of wild‐type and mutated bile salt export pumps , 2007, Hepatology.

[404]  P. Meier,et al.  Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. , 1995, Gastroenterology.

[405]  R. Kim,et al.  Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants , 2007, Pharmacogenetics and genomics.

[406]  A. Tomoda,et al.  Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes , 2006, Journal of neurochemistry.

[407]  J. Renfro,et al.  Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[408]  A. Dahan,et al.  Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[409]  Yurong Lai,et al.  Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.

[410]  H. Kusuhara,et al.  Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[411]  H. Glaeser,et al.  Variability in human hepatic MRP4 expression: influence of cholestasis and genotype , 2008, The Pharmacogenomics Journal.

[412]  Adam L VanWert,et al.  Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin , 2008, Molecular Pharmacology.

[413]  I. Arias,et al.  Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-specific Na+-Nucleoside Cotransporter (*) , 1995, The Journal of Biological Chemistry.

[414]  H. Brewer,et al.  The ABCA1 transporter functions on the basolateral surface of hepatocytes. , 2002, Biochemical and biophysical research communications.

[415]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[416]  M. Okuda,et al.  Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function. , 2004, Biochemical and biophysical research communications.

[417]  S. Misra,et al.  Familial intrahepatic cholestasis 1: Studies of localization and function , 2001, Hepatology.

[418]  H. Daniel,et al.  Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[419]  H. Kroemer,et al.  Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta , 2007, Drug Metabolism and Disposition.

[420]  G. Sachs,et al.  Topography of the membrane domain of the liver Na+-dependent bile acid transporter. , 2005, Biochemistry.

[421]  J. Nezu,et al.  Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. , 2001, Biochimica et biophysica acta.

[422]  I. Tamai,et al.  Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. , 2008, Biological & pharmaceutical bulletin.

[423]  Qiang Zhang,et al.  Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking through a Dynamin- and Clathrin-dependent Pathway* , 2008, Journal of Biological Chemistry.

[424]  H. Kroemer,et al.  The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. , 2004, Blood.

[425]  A. Enomoto,et al.  The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia , 2004, Pediatric Nephrology.

[426]  P. Meier,et al.  Differential effects of microsomal enzyme–inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2 , 2001, Hepatology.

[427]  S. Vavricka,et al.  Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver , 2002, Hepatology.

[428]  Hirotaka Matsuo,et al.  Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.

[429]  Ying Zhang,et al.  PKC regulation of the human equilibrative nucleoside transporter, hENT1 , 2002, FEBS letters.

[430]  C. Aquilante,et al.  Clinical and Genetic Determinants of Intracellular Tenofovir Diphosphate Concentrations in HIV-Infected Patients , 2008, Journal of acquired immune deficiency syndromes.

[431]  R. W. Daniel,et al.  Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[432]  I. Tamai,et al.  Organic anion transporters. , 1999, Pharmaceutical biotechnology.

[433]  J. Boyer,et al.  Functional Complementation between a Novel Mammalian Polygenic Transport Complex and an Evolutionarily Ancient Organic Solute Transporter, OSTα-OSTβ* , 2003, Journal of Biological Chemistry.

[434]  S. T. Hwang,et al.  Ontogenic Regulation of Components of Ileal Bile Acid Absorption , 2001, Experimental biology and medicine.

[435]  P. Neuvonen,et al.  ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin , 2009, Clinical pharmacology and therapeutics.

[436]  D. Keppler,et al.  A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[437]  J. Boyer,et al.  Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents , 2006 .

[438]  M. Kool,et al.  Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.

[439]  D. Postma,et al.  Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice , 2007, Respiratory research.

[440]  R. Kim,et al.  Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin , 2008, Molecular Pharmacology.

[441]  M. Gazouli,et al.  Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. , 2005, World journal of gastroenterology.

[442]  C. Cass,et al.  Immunocytochemical Demonstration of the Equilibrative Nucleoside Transporter rENT1 in Rat Sinoatrial Node , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[443]  Shufeng Zhou,et al.  Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins , 2005, Pharmaceutical Research.

[444]  S. Krähenbühl,et al.  Effect of Carnitine Deprivation on Carnitine Homeostasis and Energy Metabolism in Mice with Systemic Carnitine Deficiency , 2008, Annals of Nutrition and Metabolism.

[445]  P. Borst,et al.  Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.

[446]  Didier Raoult,et al.  Molecular identification by , 2000 .

[447]  C. Gui,et al.  Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. , 2008, European journal of pharmacology.

[448]  Allard C van der Wal,et al.  Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. , 2005, Human molecular genetics.

[449]  L. Barbot,et al.  The regionalization of PepT1, NBAT and EAAC1 transporters in the small intestine of rats are unchanged from birth to adulthood. , 2002, The Journal of nutrition.

[450]  V. Ganapathy,et al.  Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. , 2000, Biochimica et biophysica acta.

[451]  D. Beier,et al.  Regulation of hepatocyte bile salt transporters during hepatic regeneration. , 1997, The American journal of physiology.

[452]  R. Keep,et al.  Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. , 2002, The Journal of pharmacology and experimental therapeutics.

[453]  C. Handschin,et al.  Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.

[454]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS) , 2005, Drug Metabolism and Disposition.

[455]  H. Groen,et al.  The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. , 2004, European journal of cancer.

[456]  C. Cass,et al.  Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH , 2006, Circulation research.

[457]  A. Slitt,et al.  Induction of drug metabolism enzymes and transporters by oltipraz in rats , 2008, Journal of biochemical and molecular toxicology.

[458]  P. Borst,et al.  Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter. , 2003, The Biochemical journal.

[459]  P. Meier,et al.  The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.

[460]  T. Kiss,et al.  P-glycoprotein inhibition by membrane cholesterol modulation. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[461]  M. Anwer,et al.  Dephosphorylation of Ser-226 Facilitates Plasma Membrane Retention of Ntcp* , 2005, Journal of Biological Chemistry.

[462]  I. Tamai,et al.  Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells. , 2005, Reproduction.

[463]  Y. Tanaka,et al.  Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. , 2006, Biochemical pharmacology.

[464]  C. Klaassen,et al.  Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[465]  A. Groen,et al.  Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. , 1994, The American journal of pathology.

[466]  H. Koepsell,et al.  Localization of organic cation transporters OCT1 and OCT2 in rat kidney. , 2000, American journal of physiology. Renal physiology.

[467]  D. Oh,et al.  A variant 2677A allele of the MDR1 gene affects fexofenadine disposition , 2004, Clinical pharmacology and therapeutics.

[468]  M. Dean,et al.  Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. , 2004, Genomics.

[469]  P. Meier,et al.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.

[470]  S. Masuda,et al.  Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. , 2007, Biochemical pharmacology.

[471]  O. Fiehn,et al.  High Copper Selectively Alters Lipid Metabolism and Cell Cycle Machinery in the Mouse Model of Wilson Disease* , 2007, Journal of Biological Chemistry.

[472]  R. Wanders,et al.  Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2 , 2003, Journal of Inherited Metabolic Disease.

[473]  G. Dalmasso,et al.  Association of PepT1 with lipid rafts differently modulates its transport activity in polarized and nonpolarized cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[474]  H. Saito,et al.  Hormonal regulation of organic cation transporter OCT2 expression in rat kidney , 2000, FEBS letters.

[475]  H. Koepsell,et al.  Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. , 2003, American journal of physiology. Renal physiology.

[476]  Y. Liu,et al.  Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[477]  A. Lamhonwah,et al.  Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. , 2006, Biochemical and biophysical research communications.

[478]  V. Ganapathy,et al.  Mutations in Novel Organic Cation Transporter (OCTN2), an Organic Cation/Carnitine Transporter, with Differential Effects on the Organic Cation Transport Function and the Carnitine Transport Function* , 1999, The Journal of Biological Chemistry.

[479]  P. Meier,et al.  The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.

[480]  Yuichi Sugiyama,et al.  Improvement of the Oral Drug Absorption of Topotecan through the Inhibition of Intestinal Xenobiotic Efflux Transporter, Breast Cancer Resistance Protein, by Excipients , 2007, Drug Metabolism and Disposition.

[481]  V. Ling,et al.  Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. , 1998, Cancer research.

[482]  S. Bates,et al.  Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2* , 2004, Journal of Biological Chemistry.

[483]  U. Hofmann,et al.  Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[484]  S. Wright,et al.  Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. , 2004, American journal of physiology. Renal physiology.

[485]  Shuzhong Zhang,et al.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. , 2007, The Journal of clinical investigation.

[486]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[487]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[488]  C. Guillemette,et al.  Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. , 2008, Pharmacogenomics.

[489]  Stephen H Wright,et al.  Functional influence of N-glycosylation in OCT2-mediated tetraethylammonium transport. , 2006, American journal of physiology. Renal physiology.

[490]  A. Wolkoff,et al.  Topological assessment of oatp1a1: a 12-transmembrane domain integral membrane protein with three N-linked carbohydrate chains. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[491]  J. Uitto,et al.  Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elasticum , 2001, Human Genetics.

[492]  J. Boyer,et al.  Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. , 2000, Gastroenterology.

[493]  J. Lippincott-Schwartz,et al.  Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[494]  S. D. de Morais,et al.  Utility of a Novel Oatp1b2 Knockout Mouse Model for Evaluating the Role of Oatp1b2 in the Hepatic Uptake of Model Compounds , 2008, Drug Metabolism and Disposition.

[495]  W. Sadee,et al.  Genetic Variants of the Human Dipeptide Transporter PEPT1 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[496]  T. Ishikawa,et al.  Evidence for leukotriene C4 transport mediated by an ATP‐dependent glutathione S‐conjugate carrier in rat heart and liver plasma membranes , 1989, FEBS letters.

[497]  Huey-Ling Chen,et al.  Compensatory role of P‐glycoproteins in knockout mice lacking the bile salt export pump , 2009, Hepatology.

[498]  E. Schömig,et al.  Increased ergothioneine tissue concentrations in carriers of the Crohn’s disease risk-associated 503F variant of the organic cation transporter OCTN1 , 2009, Gut.

[499]  Y. Sugiyama,et al.  Characterization of the Cellular Localization, Expression Level, and Function of SNP Variants of MRP2/ABCC2 , 2004, Pharmaceutical Research.

[500]  Jin-Ming Yang,et al.  Interaction between CD147 and P-Glycoprotein and Their Regulation by Ubiquitination in Breast Cancer Cells , 2008, Chemotherapy.

[501]  M. Fromm,et al.  Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. , 2004, Pharmacogenetics.

[502]  S. Wright,et al.  Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. , 2007, American journal of physiology. Renal physiology.

[503]  C. Klaassen,et al.  Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. , 2004, Biochemical and biophysical research communications.

[504]  T. J. Cook,et al.  Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues , 2001, AAPS PharmSci.

[505]  M. Stoffel,et al.  Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism , 2001, Nature Genetics.

[506]  M. Uhr,et al.  Penetration of Endogenous Steroid Hormones Corticosterone, Cortisol, Aldosterone and Progesterone into the Brain is Enhanced in Mice Deficient for Both mdr1a and mdr1b P‐Glycoproteins , 2002, Journal of neuroendocrinology.

[507]  H. Seguchi,et al.  Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[508]  T. Litman,et al.  Identification of Intra- and Intermolecular Disulfide Bridges in the Multidrug Resistance Transporter ABCG2* , 2005, Journal of Biological Chemistry.

[509]  P. Meier,et al.  Expression of members of the multidrug resistance protein family in human term placenta. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[510]  B. Jégou,et al.  Multidrug Resistance Genes and P-Glycoprotein in the Testis of the Rat, Mouse, Guinea Pig, and Human1 , 2002, Biology of reproduction.

[511]  K. Shimokata,et al.  Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia. , 2001, Pharmacogenetics.

[512]  Richard J. Thompson,et al.  The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. , 2002, Gastroenterology.

[513]  Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease , 2005, Gut.

[514]  C. R. Crawford,et al.  Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell Line* , 1998, The Journal of Biological Chemistry.

[515]  H. Kao,et al.  cDNA cloning and genomic organization of the murine MRP7, a new ATP-binding cassette transporter. , 2002, Gene.

[516]  R. Evers,et al.  Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP , 1996, FEBS letters.

[517]  C. Klaassen,et al.  Protein kinase C suppresses rat organic anion transporting polypeptide 1- and 2-mediated uptake. , 2001, The Journal of pharmacology and experimental therapeutics.

[518]  J. Schuetz,et al.  Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[519]  P. Meier,et al.  Differential expression of bile salt and organic anion transporters in developing rat liver. , 2004, Journal of hepatology.

[520]  S. Nigam,et al.  Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues , 2007, Nature Clinical Practice Nephrology.

[521]  O. Gavrilova,et al.  In vivo relevance of Mrp2-mediated biliary excretion of the Amanita mushroom toxin demethylphalloin. , 2007, Biochimica et biophysica acta.

[522]  E. Burchard,et al.  Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin , 2009, Pharmacogenetics and genomics.

[523]  T. Fujita,et al.  Effects of structure on binding to the 2,3,7,8-TCDD receptor protein and AHH induction--halogenated biphenyls. , 1985, Environmental health perspectives.

[524]  D. Postma,et al.  Multidrug resistance related molecules in human and murine lung. , 2002, Journal of clinical pathology.

[525]  Y. Sugiyama,et al.  Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil , 2004, Journal of Pharmacology and Experimental Therapeutics.

[526]  G. L. Youngblood,et al.  Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. , 2004, American journal of physiology. Renal physiology.

[527]  I. Arias,et al.  Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[528]  S. Wright,et al.  Sex Differences in the mRNA, Protein, and Functional Expression of Organic Anion Transporter (Oat) 1, Oat3, and Organic Cation Transporter (Oct) 2 in Rabbit Renal Proximal Tubules , 2006, Journal of Pharmacology and Experimental Therapeutics.

[529]  A. Enomoto,et al.  Role of human organic anion transporter 4 in the transport of ochratoxin A. , 2002, Biochimica et biophysica acta.

[530]  N. Ballatori,et al.  Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1. , 2002, Molecular pharmacology.

[531]  Fanfan Zhou,et al.  Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[532]  P. Dawson,et al.  OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. , 2005, Hepatology.

[533]  O. van Tellingen,et al.  Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.

[534]  I. Tamai,et al.  Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. , 1999, Journal of pharmaceutical sciences.

[535]  Jian Yang,et al.  Oxysterol 22(R)-Hydroxycholesterol Induces the Expression of the Bile Salt Export Pump through Nuclear Receptor Farsenoid X Receptor but Not Liver X Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[536]  C. Endres,et al.  Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[537]  D. Besselsen,et al.  Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease , 2007, Drug Metabolism and Disposition.

[538]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[539]  H. Daniel,et al.  Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system , 2005, The Journal of comparative neurology.

[540]  C. Klaassen,et al.  Endocrine regulation of rat organic anion transporters. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[541]  J. Manautou,et al.  Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[542]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[543]  M. Barrand,et al.  A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. , 1994, Journal of the National Cancer Institute.

[544]  Yuichi Sugiyama,et al.  Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.

[545]  J. Uitto,et al.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms , 2009, Experimental dermatology.

[546]  Shuzhong Zhang,et al.  Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family , 2007, Journal of Pharmacology and Experimental Therapeutics.

[547]  Masahiko Watanabe,et al.  Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte‐derived soluble factor(s) , 2004, Journal of neurochemistry.

[548]  A. Parkinson,et al.  Regulation of drug transporter gene expression by nuclear receptors. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[549]  Y. Sawada,et al.  Functional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta , 2005, Journal of Pharmacology and Experimental Therapeutics.

[550]  Sarfaraz Ahmad,et al.  Handling of the Homocysteine S-Conjugate of Methylmercury by Renal Epithelial Cells: Role of Organic Anion Transporter 1 and Amino Acid Transporters , 2005, Journal of Pharmacology and Experimental Therapeutics.

[551]  A. Sartorelli,et al.  Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[552]  M. Donovan,et al.  Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues. , 2007, Molecular pharmaceutics.

[553]  S. Bates,et al.  ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy , 2005, Cancer biology & therapy.

[554]  J. Uitto,et al.  Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-)). , 2009, The Journal of investigative dermatology.

[555]  M. Karin,et al.  Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis , 2007, Drug Metabolism and Disposition.

[556]  M. Relling,et al.  Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. , 2008, Cancer Research.

[557]  A. Hutchinson,et al.  Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. , 2001, Gene.

[558]  K. Bock,et al.  Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. , 2006, Biochemical pharmacology.

[559]  P. Meier,et al.  Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[560]  S. Terry,et al.  Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum , 2000, Nature Genetics.

[561]  M Dietel,et al.  Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. , 1999, Journal of the National Cancer Institute.

[562]  P. Pávek,et al.  Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. , 2008, Toxicology letters.

[563]  J. Boyer,et al.  Nuclear factor erythroid 2–related factor 2 is a positive regulator of human bile salt export pump expression , 2009, Hepatology.

[564]  Katsuhisa Inoue,et al.  Molecular Identification and Functional Characterization of Rat Multidrug and Toxin Extrusion Type Transporter 1 as an Organic Cation/H+ Antiporter in the Kidney , 2006, Drug Metabolism and Disposition.

[565]  P. Meier,et al.  Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury , 2007, Pharmacogenetics and genomics.

[566]  T. Ishikawa,et al.  Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. , 2009, Advanced drug delivery reviews.

[567]  T. Ishikawa,et al.  Re‐evaluation and functional classification of non‐synonymous single nucleotide polymorphisms of the human ATP‐binding cassette transporter ABCG2 , 2007, Cancer science.

[568]  H. Tomita,et al.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye. , 2003, Investigative ophthalmology & visual science.

[569]  K. Yoshinari,et al.  Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. , 2007, Drug metabolism and pharmacokinetics.

[570]  Markus Grube,et al.  EXPRESSION, LOCALIZATION, AND FUNCTION OF THE CARNITINE TRANSPORTER OCTN2 (SLC22A5) IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.

[571]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[572]  Daying Zhang,et al.  Ontogeny of Expression of Organic Anion Transporters 1 and 3 in Ovine Fetal and Neonatal Kidney , 2005, Experimental biology and medicine.

[573]  P. Meier,et al.  Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.

[574]  K. Toshimori,et al.  Expression of novel organic cation/carnitine transporter (OCTN2) in the mouse pancreas. , 2005, Tissue & cell.

[575]  L. Benet,et al.  Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.

[576]  R. Evans,et al.  The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity* , 2004, Journal of Biological Chemistry.

[577]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[578]  P. Gros,et al.  Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.

[579]  J. Wijnholds,et al.  The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. , 1999, Cancer research.

[580]  H. Nakauchi,et al.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.

[581]  Joanne Wang,et al.  Molecular Determinants of Substrate Selectivity of a Novel Organic Cation Transporter (PMAT) in the SLC29 Family* , 2007, Journal of Biological Chemistry.

[582]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[583]  D. Keppler,et al.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.

[584]  Ning Li,et al.  Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. , 2004, Molecular pharmacology.

[585]  J. Nezu,et al.  Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. , 2002, The Journal of pharmacology and experimental therapeutics.

[586]  R. Cecchelli,et al.  Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood–brain barrier , 2007, Journal of neurochemistry.

[587]  P. Denéfle,et al.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[588]  P. Johnston,et al.  The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites , 2005, Molecular Cancer Therapeutics.

[589]  M. J. van de Vijver,et al.  Expression of the breast cancer resistance protein in breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[590]  H. Nishimori,et al.  A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. , 1998, Biochemical and biophysical research communications.

[591]  D. Adams,et al.  Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine , 2004, BMC gastroenterology.

[592]  Y. Kato,et al.  PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2 , 2005, Molecular Pharmacology.

[593]  S. Masuda,et al.  Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats. , 2007, Biochemical pharmacology.

[594]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[595]  J. Gallo,et al.  The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. , 2003, Cancer research.

[596]  M. Beaussier,et al.  Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[597]  Y. Sugiyama,et al.  Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.

[598]  R. Neubert,et al.  Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). , 2005, Biochemical pharmacology.

[599]  K. Fukushi,et al.  Noninvasive and Quantitative Assessment of the Function of Multidrug Resistance-Associated Protein 1 in the Living Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[600]  Conrad C. Huang,et al.  Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants , 2006, Journal of Pharmacology and Experimental Therapeutics.

[601]  G. Burckhardt,et al.  Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. , 2007, American journal of physiology. Renal physiology.

[602]  V. Ganapathy,et al.  Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain* , 1998, The Journal of Biological Chemistry.

[603]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.

[604]  P. Glue,et al.  Intestinal Absorption of Ribavirin Is Preferentially Mediated by the Na+-Nucleoside Purine (Nl) Transporter , 1998, Pharmaceutical Research.

[605]  A. Schinkel,et al.  TRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) , 2005, Drug Metabolism and Disposition.

[606]  J. Wijnholds,et al.  Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells* , 2003, The Journal of Biological Chemistry.

[607]  W. Haefeli,et al.  Localization of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Lipid Rafts/Caveolae and Modulation of Its Activity by Cholesterol in Vitro , 2007, Journal of Pharmacology and Experimental Therapeutics.

[608]  P. McNamara,et al.  Active Transport of Nitrofurantoin into Human Milk , 2001, Pharmacotherapy.

[609]  D. Rosskopf,et al.  Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1 , 2008, Pharmacogenetics and genomics.

[610]  Yoshikatsu Kanai,et al.  The Multivalent PDZ Domain-containing Protein PDZK1 Regulates Transport Activity of Renal Urate-Anion Exchanger URAT1 via Its C Terminus* , 2004, Journal of Biological Chemistry.

[611]  Sarfaraz Ahmad,et al.  Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1. , 2005, Kidney international.

[612]  D. Butterfield,et al.  Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice , 2006, Molecular Cancer Therapeutics.

[613]  I. Roninson,et al.  Structure and expression of the human MDR (P-glycoprotein) gene family , 1989, Molecular and cellular biology.

[614]  M. Breen,et al.  pABC11 (Also Known as MOAT-C and MRP5), a Member of the ABC Family of Proteins, Has Anion Transporter Activity but Does Not Confer Multidrug Resistance When Overexpressed in Human Embryonic Kidney 293 Cells* , 1999, The Journal of Biological Chemistry.

[615]  S. Masuda,et al.  Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2. , 2009, Biochemical pharmacology.

[616]  V. Ganapathy,et al.  β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.

[617]  D. Keppler,et al.  Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6* , 2001, The Journal of Biological Chemistry.

[618]  Bruno Stieger,et al.  Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. , 2009, American journal of physiology. Cell physiology.

[619]  J. Fritschy,et al.  Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier , 2006, Neuroscience.

[620]  Stephen A Baldwin,et al.  Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. , 2009, American journal of physiology. Renal physiology.

[621]  Tianxin Yang,et al.  Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. , 1999, American journal of physiology. Renal physiology.

[622]  T. Hasegawa,et al.  Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. , 2006, Life sciences.

[623]  J. Nezu,et al.  Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[624]  F. Lammert,et al.  Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene , 2006, Gut.

[625]  G. Merino,et al.  Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. , 2006, Journal of veterinary pharmacology and therapeutics.

[626]  B. Vig,et al.  Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. , 2003, Biochemical and biophysical research communications.

[627]  D. Schrenk,et al.  A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. , 2002, Pharmacogenetics.

[628]  M. Karin,et al.  Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. , 2007, Drug metabolism and disposition: the biological fate of chemicals.

[629]  U. Brinkmann,et al.  Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. , 2002, Pharmacogenetics.

[630]  K. Miyamoto,et al.  Loss of wild‐type carrier‐mediated L‐carnitine transport activity in hepatocytes of juvenile visceral steatosis mice , 1999, Hepatology.

[631]  Y. Kato,et al.  Organic Cation/Carnitine Transporter OCTN2 (Slc22a5) Is Responsible for Carnitine Transport across Apical Membranes of Small Intestinal Epithelial Cells in Mouse , 2006, Molecular Pharmacology.

[632]  I. Tamai,et al.  Transport of organic cations across the blood-testis barrier. , 2007, Molecular pharmaceutics.

[633]  Jan Stankiewicz,et al.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. , 2003, Pharmacogenetics.

[634]  D. Keppler,et al.  Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin‐johnson syndrome , 2000, Hepatology.

[635]  C. Klaassen,et al.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[636]  Masaki Kobayashi,et al.  Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells. , 2009, Biochimica et biophysica acta.

[637]  P. Meier,et al.  Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver , 2001 .

[638]  A. Schinkel,et al.  Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. , 2009, Advanced drug delivery reviews.

[639]  K. Siminovitch,et al.  SLC22A4 polymorphisms implicated in rheumatoid arthritis and Crohn's disease are not associated with rheumatoid arthritis in a Canadian Caucasian population. , 2005, Arthritis and rheumatism.

[640]  H. Endou,et al.  Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[641]  H. Kusuhara,et al.  Transcriptional Regulation of Human and Mouse Organic Anion Transporter 1 by Hepatocyte Nuclear Factor 1 α/β , 2008, Journal of Pharmacology and Experimental Therapeutics.

[642]  Xingguo Cheng,et al.  Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.

[643]  S. Waxman,et al.  Disruption of cAMP and Prostaglandin E2 Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive Response , 2007, Molecular Pharmacology.

[644]  D. Keppler,et al.  The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.

[645]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[646]  G. Kruh,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .

[647]  L. Varticovski,et al.  Mechanisms by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[648]  P. Meier,et al.  Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. , 2003, Biochimica et biophysica acta.

[649]  R. Kim,et al.  Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[650]  J. Schellens,et al.  Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. , 2000, Journal of the National Cancer Institute.

[651]  G. Rudenko,et al.  N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.

[652]  G. Koren,et al.  Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. , 2008, Placenta.

[653]  N. Longo,et al.  Tyrosine Residues Affecting Sodium Stimulation of Carnitine Transport in the OCTN2 Carnitine/Organic Cation Transporter* , 2004, Journal of Biological Chemistry.

[654]  T. Abe,et al.  Molecular characterization of human and rat organic anion transporter OATP-D. , 2003, American journal of physiology. Renal physiology.

[655]  D. Keppler,et al.  ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. , 1996, The Biochemical journal.

[656]  N. Niikawa,et al.  A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland , 2007, Human Genetics.

[657]  P. Dawson,et al.  Identification of a Mutation in the Ileal Sodium-dependent Bile Acid Transporter Gene That Abolishes Transport Activity (*) , 1995, The Journal of Biological Chemistry.

[658]  Xin He,et al.  Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. , 2005, Journal of the American Society of Nephrology : JASN.

[659]  K. Giacomini,et al.  Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.

[660]  Xingguo Cheng,et al.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression. , 2007, Biochemical pharmacology.

[661]  J. Bene,et al.  Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. , 2006, World journal of gastroenterology.

[662]  G. Peters,et al.  MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[663]  C. Klaassen,et al.  Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[664]  Mei-Hwei Chang,et al.  Developmental expression of canalicular transporter genes in human liver. , 2004, Journal of hepatology.

[665]  B. Sarkadi,et al.  Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells. , 2003, Biochemical and biophysical research communications.

[666]  Yuichi Sugiyama,et al.  Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. , 2003, Biochemical and biophysical research communications.

[667]  M. L. Calonge,et al.  Ontogeny of Na+/l-carnitine transporter and of γ-trimethylaminobutyraldehyde dehydrogenase and γ-butyrobetaine hydroxylase genes expression in rat kidney , 2009, Mechanisms of Ageing and Development.

[668]  T. Mizuno,et al.  Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin , 2009, Molecular Pharmacology.

[669]  Y. Kato,et al.  Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. , 2008, Drug metabolism and pharmacokinetics.

[670]  D. Goldstein,et al.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. , 2006, Human molecular genetics.

[671]  Conrad C. Huang,et al.  Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. , 2002, Pharmacogenetics.

[672]  H. Saito,et al.  Molecular cloning and tissue distribution of rat peptide transporter PEPT2. , 1996, Biochimica et biophysica acta.

[673]  T. Hirano,et al.  Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[674]  F. Lang,et al.  Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.

[675]  A. Engel,et al.  Primary systemic carnitine deficiency , 1981, Neurology.

[676]  D. Keppler,et al.  Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C–dependent mechanisms in cholestatic rat liver , 2001, Hepatology.

[677]  Zhe-Sheng Chen,et al.  Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. , 2009, Cancer research.

[678]  D. Moore,et al.  Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[679]  Kuniharu Nakai,et al.  Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model , 2001, Digestive Diseases and Sciences.

[680]  J. C. Jones,et al.  A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. , 1998, Journal of immunology.

[681]  M. Hediger,et al.  Distribution of peptide transporter PEPT2 mRNA in the rat nervous system , 1999, Anatomy and Embryology.

[682]  R. Kim,et al.  Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. , 2006, Gastroenterology.

[683]  J. Wijnholds,et al.  Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. , 2006, Journal of hepatology.

[684]  M. Barrand,et al.  Localisation of breast cancer resistance protein in microvessel endothelium of human brain , 2002, Neuroreport.

[685]  I. Paulsen,et al.  The multidrug efflux protein NorM is a prototype of a new family of transporters , 1999, Molecular microbiology.

[686]  Donald W. Miller,et al.  Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[687]  A. Klein-Szanto,et al.  Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. , 2000, Journal of the National Cancer Institute.

[688]  C. Ackerley,et al.  OCTN3 is a mammalian peroxisomal membrane carnitine transporter. , 2005, Biochemical and biophysical research communications.

[689]  J. Petrick,et al.  TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE , 2006, Drug Metabolism and Disposition.

[690]  Richard J. Thompson,et al.  Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency , 2006, Hepatology.

[691]  Conrad C. Huang,et al.  Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). , 2007, Pharmacogenetics and genomics.

[692]  Bhandari,et al.  Fumonisin toxicity in a transgenic mouse model lacking the mdr1a/1b P-glycoprotein genes. , 2000, Environmental toxicology and pharmacology.

[693]  A. Klein-Szanto,et al.  Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. , 2007, Cancer research.

[694]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[695]  K. Verbeke,et al.  Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft Recipients , 2006, Transplantation.

[696]  A. Hofmann,et al.  Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. , 1997, Gastroenterology.

[697]  J. Nezu,et al.  Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2* , 1998, The Journal of Biological Chemistry.

[698]  F. Suchy,et al.  Multiple Factors Regulate the Rat Liver Basolateral Sodium-dependent Bile Acid Cotransporter Gene Promoter* , 1996, The Journal of Biological Chemistry.

[699]  A. Groen,et al.  Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. , 1995, The Journal of clinical investigation.

[700]  R. Kim,et al.  Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. , 2008, Cancer research.

[701]  M. Romero,et al.  Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.

[702]  S. Choudhuri,et al.  Cloning, expression, and ontogeny of mouse organic anion-transporting polypeptide-5, a kidney-specific organic anion transporter. , 2001, Biochemical and biophysical research communications.

[703]  Y. Kato,et al.  PDZK1 Regulates Two Intestinal Solute Carriers (Slc15a1 and Slc22a5) in Mice , 2008, Drug Metabolism and Disposition.

[704]  H. Kusuhara,et al.  P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier , 2008, Drug Metabolism and Disposition.

[705]  P. Meier,et al.  Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. , 1996, The Biochemical journal.

[706]  M. L. Calonge,et al.  OCTN3: A Na+‐independent L‐carnitine transporter in enterocytes basolateral membrane , 2005, Journal of cellular physiology.

[707]  J. Nezu,et al.  Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice* , 2000, The Journal of Biological Chemistry.

[708]  K. Amsler,et al.  Regulation of mOAT-mediated Organic Anion Transport by Okadaic Acid and Protein Kinase C in LLC-PK1 Cells* , 2000, The Journal of Biological Chemistry.

[709]  D. Piwnica-Worms,et al.  Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. , 2000, Biochemistry.

[710]  S. Yao,et al.  Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. , 1994, The Journal of biological chemistry.

[711]  R. Miller,et al.  Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice. , 2000, Developmental and comparative immunology.

[712]  V. Ling,et al.  Identification of a sister gene to P-glycoprotein. , 1995, Cancer research.

[713]  T. Matsuishi,et al.  Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. , 1999, Human molecular genetics.

[714]  J. Boyer,et al.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. , 1998, The Journal of clinical investigation.

[715]  C. Funk,et al.  Substrate-Dependent Drug-Drug Interactions between Gemfibrozil, Fluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1, and OATP1B3 , 2007, Drug Metabolism and Disposition.

[716]  D. Keppler,et al.  Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. , 2001, Gastroenterology.

[717]  I. Tamai,et al.  Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.

[718]  Peijin Zhang,et al.  Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes , 2005, Molecular Pharmacology.

[719]  J. Testa,et al.  Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. , 1998, Journal of the National Cancer Institute.

[720]  L. M. Hodges,et al.  Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms , 2008, Journal of Pharmacology and Experimental Therapeutics.

[721]  K. Boekelheide,et al.  XENOBIOTIC AND ENDOBIOTIC TRANSPORTER MRNA EXPRESSION IN THE BLOOD-TESTIS BARRIER , 2005, Drug Metabolism and Disposition.

[722]  H. Kusuhara,et al.  Investigation of Efflux Transport of Dehydroepiandrosterone Sulfate and Mitoxantrone at the Mouse Blood-Brain Barrier: A Minor Role of Breast Cancer Resistance Protein , 2005, Journal of Pharmacology and Experimental Therapeutics.

[723]  C. R. Crawford,et al.  Cloning, genomic organization and chromosomal localization of the gene encoding the murine sodium-dependent, purine-selective, concentrative nucleoside transporter (CNT2). , 2000, Gene.

[724]  C. Webster,et al.  Protein kinase Cδ mediates cyclic adenosine monophosphate–stimulated translocation of sodium taurocholate cotransporting polypeptide and multidrug resistant associated protein 2 in rat hepatocytes , 2007, Hepatology.

[725]  K. Motojima,et al.  PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. , 2007, Biological & pharmaceutical bulletin.

[726]  A. Calcagno,et al.  Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor , 2006, Molecular Cancer Therapeutics.

[727]  K. Faber,et al.  Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells , 2008, Hepatology.

[728]  J. Boyer,et al.  Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[729]  D. Keppler,et al.  Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[730]  A. Schinkel,et al.  Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.

[731]  P. Meier,et al.  Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[732]  N. Ballatori,et al.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway , 2009, Proceedings of the National Academy of Sciences.

[733]  Yuichi Sugiyama,et al.  Evaluation of the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) and Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in The Urinary Excretion of Sulfate and Glucuronide Metabolites of Edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one) , 2007, Drug Metabolism and Disposition.

[734]  H. Takikawa,et al.  Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats , 2003, Journal of gastroenterology and hepatology.

[735]  M. Takano,et al.  cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. , 1996, Biochemical and biophysical research communications.

[736]  M. Kool,et al.  Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.

[737]  R. Kim,et al.  Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2). , 2008, Drug metabolism reviews.

[738]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. , 1999, Advances in experimental medicine and biology.

[739]  P. Giral,et al.  Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. , 2008, Pharmacogenomics.

[740]  G. Decorti,et al.  Physiological regulation of P‐glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny , 2003, Development, growth & differentiation.

[741]  M. Kuwano,et al.  Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. , 2002, Cancer research.

[742]  J. Wijnholds,et al.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[743]  R. Stocco,et al.  Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[744]  Jonathan C. Cohen,et al.  ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion* , 2003, Journal of Biological Chemistry.

[745]  J. Mackey,et al.  Differential Transport of Cytosine-Containing Nucleosides by Recombinant Human Concentrative Nucleoside Transporter Protein hCNT1 , 2000, Nucleosides, nucleotides & nucleic acids.

[746]  G. Amidon,et al.  Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein , 2001, AAPS PharmSci.

[747]  C. Beglinger,et al.  MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT , 2005, Drug Metabolism and Disposition.

[748]  V. Ling,et al.  Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P‐glycoprotein , 2003, Hepatology.

[749]  E. Eicher,et al.  Stimulation of growth in the little mouse. , 1976, The Journal of endocrinology.

[750]  Y. Kanai,et al.  Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. , 2000, The Journal of pharmacology and experimental therapeutics.

[751]  G. Merino,et al.  Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones. , 2009, Journal of veterinary pharmacology and therapeutics.

[752]  P. Duan,et al.  Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A. , 2012, International journal of biochemistry and molecular biology.

[753]  D. Keppler,et al.  Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. , 1996, European journal of biochemistry.

[754]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[755]  L. Bain,et al.  The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. , 2003, Toxicology letters.

[756]  J. Boyer,et al.  The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. , 2002, The Journal of clinical investigation.

[757]  Guoyu Pan,et al.  Abcg2/Bcrp1 Mediates the Polarized Transport of Antiretroviral Nucleosides Abacavir and Zidovudine , 2007, Drug Metabolism and Disposition.

[758]  D. Oh,et al.  Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers , 2005, Clinical pharmacology and therapeutics.

[759]  S. Grimm,et al.  ATP-DEPENDENT TRANSPORT OF ROSUVASTATIN IN MEMBRANE VESICLES EXPRESSING BREAST CANCER RESISTANCE PROTEIN , 2006, Drug Metabolism and Disposition.

[760]  Y. Sugiyama,et al.  Functional Analysis of SNPs Variants of BCRP/ABCG2 , 2004, Pharmaceutical Research.

[761]  D. Keppler,et al.  ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4) , 2008, Journal of Pharmacology and Experimental Therapeutics.

[762]  J. van Lunzen,et al.  Relevance of the Organic Cation Transporters 1 and 2 for Antiretroviral Drug Therapy in Human Immunodeficiency Virus Infection , 2008, Drug Metabolism and Disposition.

[763]  H. Kusuhara,et al.  Regulation of the Expression of Human Organic Anion Transporter 3 by Hepatocyte Nuclear Factor 1α/β and DNA Methylation , 2006, Molecular Pharmacology.

[764]  D. Mangelsdorf,et al.  Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. , 2002, Gastroenterology.

[765]  R. Kerwin,et al.  Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters , 2003, British journal of pharmacology.

[766]  C. Klaassen,et al.  Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[767]  D. Keppler,et al.  Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. , 1999, Gastroenterology.

[768]  Joe Palandra,et al.  Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe , 2008, Pharmacogenetics and genomics.

[769]  J. Boyer,et al.  Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. , 1996, Gastroenterology.

[770]  T. Eschenhagen,et al.  High‐dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations , 2006, Clinical pharmacology and therapeutics.

[771]  D D Breimer,et al.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.

[772]  J. Moseley,et al.  Myosin II Regulatory Light Chain Is Required for Trafficking of Bile Salt Export Protein to the Apical Membrane in Madin-Darby Canine Kidney Cells* , 2005, Journal of Biological Chemistry.

[773]  J. Nezu,et al.  OCTN2-mediated transport of carnitine in isolated Sertoli cells. , 2005, Reproduction.

[774]  R. Keep,et al.  Mechanisms of Cefadroxil Uptake in the Choroid Plexus: Studies in Wild-Type and PEPT2 Knockout Mice , 2004, Journal of Pharmacology and Experimental Therapeutics.

[775]  Yi Wang,et al.  Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin , 2008, Drug Metabolism and Disposition.

[776]  D. Keppler,et al.  Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.

[777]  Conrad C. Huang,et al.  The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene , 2008, Journal of Pharmacology and Experimental Therapeutics.

[778]  Y. Kato,et al.  Screening of the Interaction Between Xenobiotic Transporters and PDZ Proteins , 2004, Pharmaceutical Research.

[779]  C. Grimm,et al.  Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium. , 2002, Investigative ophthalmology & visual science.

[780]  Xin Wang,et al.  Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. , 2003, Molecular pharmacology.

[781]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[782]  Z. Bacso,et al.  Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[783]  I. Roots,et al.  In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms , 2006, Pharmacogenetics and genomics.

[784]  T. Ishikawa,et al.  Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. , 2007, Journal of experimental therapeutics & oncology.

[785]  Martin F. Fromm,et al.  The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3 , 2007, Drug Metabolism and Disposition.

[786]  T. Langmann,et al.  Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.

[787]  D. Thakker,et al.  Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) , 2005, Journal of Pharmacology and Experimental Therapeutics.

[788]  D. Moore,et al.  Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.

[789]  P. Meier,et al.  Functional characterization of the mouse organic-anion-transporting polypeptide 2. , 2002, Biochimica et biophysica acta.

[790]  L. Bain,et al.  Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. , 1999, Cancer research.

[791]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[792]  R. Ringseis,et al.  Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. , 2007, Pharmacological research.

[793]  K. Roberg,et al.  Molecular cloning and characterization of a novel liver-specific transport protein. , 1994, Journal of cell science.

[794]  A. Wolkoff,et al.  Characterization of the mechanisms involved in the gender differences in hepatic taurocholate uptake. , 1999, The American journal of physiology.

[795]  D. Eastmond,et al.  Postulated Carbon Tetrachloride Mode of Action: A Review , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[796]  H. Kusuhara,et al.  The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. , 2004, Journal of the American Society of Nephrology : JASN.

[797]  K. Brouwer,et al.  Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3–/– and Abcc4–/– Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[798]  B. Staels,et al.  Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. , 2003, The Biochemical journal.

[799]  Y. Moriyama,et al.  Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[800]  Xingguo Cheng,et al.  Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. , 2008, Life sciences.

[801]  M. Iyo,et al.  Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. , 2006, Alcoholism, clinical and experimental research.

[802]  D. Keppler,et al.  A Naturally Occurring Mutation in the SLC21A6Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake Transporter* , 2002, The Journal of Biological Chemistry.

[803]  A. Enomoto,et al.  Interactions of human organic anion as well as cation transporters with indoxyl sulfate. , 2003, European journal of pharmacology.

[804]  Vincenzo,et al.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.

[805]  J. Beijnen,et al.  Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice. , 1996, Journal of the National Cancer Institute.

[806]  G. Reid,et al.  Cloning of a Human Renal p–Aminohippurate Transporter, hROAT1 , 2008, Kidney and Blood Pressure Research.

[807]  V. Vallon,et al.  Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice* , 2006, Journal of Biological Chemistry.

[808]  C. Klaassen,et al.  Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[809]  T. Willson,et al.  Peroxisome proliferator activated receptor agonists. , 1997, EXS.

[810]  S. Vavricka,et al.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[811]  Jie Liu,et al.  Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice. , 2005, Biochemical pharmacology.

[812]  D. Keppler,et al.  Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide* , 2000, The Journal of Biological Chemistry.

[813]  C. Cass,et al.  Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. , 1999, Brain research. Molecular brain research.

[814]  A Felipe,et al.  Developmental regulation of the concentrative nucleoside transporters CNT1 and CNT2 in rat liver. , 2001, Journal of hepatology.

[815]  U. Broeckel,et al.  Contribution of OCTN Variants Within the IBD5 Locus to Pediatric Onset Crohn's Disease , 2006, The American Journal of Gastroenterology.

[816]  Wei Li,et al.  The 5′-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation , 2010, Molecular Pharmacology.

[817]  J. Kingdom,et al.  Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. , 2006, Placenta.

[818]  I. Tamai,et al.  Predominant Contribution of Rat Organic Anion Transporting Polypeptide-2 (Oatp2) to Hepatic Uptake of β-Lactam Antibiotics , 2008, Pharmaceutical Research.

[819]  J. Schellens,et al.  Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[820]  T. Abe,et al.  Identification and characterization of novel rat and human gonad-specific organic anion transporters. , 2003, Molecular endocrinology.

[821]  Y. Sawada,et al.  CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2005, Drug Metabolism and Disposition.

[822]  Yuichi Sugiyama,et al.  Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans , 2008, Clinical pharmacology and therapeutics.

[823]  Markus Grube,et al.  Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. , 2005, The American journal of pathology.

[824]  J. Mackey,et al.  Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. , 1998, Molecular membrane biology.

[825]  Jie Liu,et al.  Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. , 2002, Toxicology.

[826]  I. Schoots,et al.  Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.

[827]  K. Allen,et al.  Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. , 2000, The Biochemical journal.

[828]  T. Litman,et al.  Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. , 2006, Cancer letters.

[829]  P. Meier,et al.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. , 1994, The Journal of clinical investigation.

[830]  M. Vore,et al.  Expression and localization of multidrug resistant protein mrp2 in rat small intestine. , 2000, The Journal of pharmacology and experimental therapeutics.

[831]  U. Brinkmann,et al.  Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart. , 2003, The American journal of pathology.

[832]  D. Keppler,et al.  Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). , 2004, Pharmacogenetics.

[833]  T. Uchiumi,et al.  Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) , 1999, FEBS letters.

[834]  T. Komatsu,et al.  Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter. , 2007, American journal of physiology. Cell physiology.

[835]  Carol E. Cass,et al.  Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes* , 2005, Journal of Biological Chemistry.

[836]  A. Pandya,et al.  Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. , 2001, American journal of human genetics.

[837]  D. Bell,et al.  Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. , 1998, Cancer research.

[838]  F. Gonzalez,et al.  Regulation of drug transporters by the farnesoid X receptor in mice. , 2004, Molecular pharmaceutics.

[839]  H. Koepsell,et al.  Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.

[840]  H. Kusuhara,et al.  Contribution of Organic Anion Transporter 3 (Slc22a8) to the Elimination of p-Aminohippuric Acid and Benzylpenicillin across the Blood-Brain Barrier , 2003, Journal of Pharmacology and Experimental Therapeutics.

[841]  M. Haberl,et al.  Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. , 2005, Journal of hepatology.

[842]  Masayuki Yamamoto,et al.  Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.

[843]  F. Russel,et al.  The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. , 2002, Journal of the American Society of Nephrology : JASN.

[844]  R. Messing,et al.  The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice , 2007, Genes, brain, and behavior.

[845]  I. Rubio-Aliaga,et al.  Cloning and characterization of the gene encoding the mouse peptide transporter PEPT2. , 2000, Biochemical and biophysical research communications.

[846]  J. Wijnholds,et al.  Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. , 2003, Molecular pharmacology.

[847]  A. Jongsma,et al.  Tissue distribution of the human MDR3 P-glycoprotein. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[848]  H. Kroemer,et al.  Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex , 2007, The Pharmacogenomics Journal.

[849]  I. Song,et al.  Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake , 2012, Biopharmaceutics & drug disposition.

[850]  K. Zatloukal,et al.  Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[851]  F. Brosius,et al.  Developmental Expression of PEPT1 and PEPT2 in Rat Small Intestine, Colon, and Kidney , 2001, Pediatric Research.

[852]  C. Klaassen,et al.  Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[853]  R. Green,et al.  Molecular cloning and characterization of the murine bile salt export pump. , 2000, Gene.

[854]  J. Camakaris,et al.  Distinct Functional Roles for the Menkes and Wilson Copper Translocating P-type ATPases in Human Placental Cells , 2007, Cellular Physiology and Biochemistry.

[855]  Daxi Sun,et al.  Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. , 2007, Cancer research.

[856]  Yuichi Sugiyama,et al.  Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs , 2006, Drug Metabolism and Disposition.

[857]  A. Mahfoudi,et al.  Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.

[858]  C. Meisel,et al.  Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease , 2007, European Journal of Clinical Pharmacology.

[859]  C. Paulusma,et al.  Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content , 2009, Journal of Biological Chemistry.

[860]  Masayuki Yamamoto,et al.  Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[861]  Hiroshi Suzuki,et al.  Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)* , 1999, The Journal of Biological Chemistry.

[862]  S. Vavricka,et al.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes , 2006 .

[863]  C. Cass,et al.  Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. , 1996, The Biochemical journal.

[864]  Amy G. Aslamkhan,et al.  Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. , 2003, Molecular pharmacology.

[865]  Conrad C. Huang,et al.  Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1) , 2005, Pharmacogenetics and genomics.

[866]  P. Dawson,et al.  Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). , 1997, The Journal of clinical investigation.

[867]  K. Nakao,et al.  Kidney‐specific expression of a novel mouse organic cation transporter‐like protein , 1997, FEBS letters.

[868]  Y. Sawada,et al.  EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2006, Drug Metabolism And Disposition.

[869]  H. Kusuhara,et al.  Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.

[870]  Ulrich Hoffmann,et al.  Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition , 2006, Expert opinion on drug metabolism & toxicology.

[871]  E. Holtzman,et al.  Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). , 1999, Biochemical and biophysical research communications.

[872]  Jürgen Roth,et al.  ABC‐transporters are localized in caveolin‐1‐positive and reggie‐1‐negative and reggie‐2‐negative microdomains of the canalicular membrane in rat hepatocytes , 2009, Hepatology.

[873]  Y. Kanai,et al.  The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity. , 2006, Kidney international.

[874]  T. Suzuki,et al.  Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. , 2003, Placenta.

[875]  Robert W. Robey,et al.  Breast Cancer Resistance Protein , 2006 .

[876]  D. Keppler,et al.  The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.

[877]  G. Kruh,et al.  Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice , 2007, Cancer and Metastasis Reviews.

[878]  S. Bates,et al.  Single nucleotide polymorphisms modify the transporter activity of ABCG2 , 2005, Cancer Chemotherapy and Pharmacology.

[879]  Y. Kanai,et al.  Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter* , 1997, The Journal of Biological Chemistry.

[880]  G. Burckhardt,et al.  Structure of renal organic anion and cation transporters. , 2000, American journal of physiology. Renal physiology.

[881]  F. Suchy,et al.  cAMP increases liver Na+-taurocholate cotransport by translocating transporter to plasma membranes. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[882]  S. Nakken,et al.  ABCB4 sequence variations in young adults with cholesterol gallstone disease , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[883]  Jonathan C. Cohen,et al.  Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[884]  M. Kool,et al.  A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome , 1997, Hepatology.

[885]  M. Tomi,et al.  Gene expression profiles of ATP-binding cassette transporter A and C subfamilies in mouse retinal vascular endothelial cells. , 2008, Microvascular research.

[886]  D. Häussinger,et al.  Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. , 2006, Gastroenterology.

[887]  Katrin Wlcek,et al.  Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma , 2008, Cancer biology & therapy.

[888]  K. Faber,et al.  Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease , 2006, Scandinavian journal of gastroenterology.

[889]  T. Gilliam,et al.  Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.

[890]  Teruhiko Yoshida,et al.  Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. , 2008, Drug metabolism and pharmacokinetics.

[891]  J. Nezu,et al.  Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human , 2004, Journal of Pharmacology and Experimental Therapeutics.

[892]  J. Megyesi,et al.  Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. , 1997, Nephron.

[893]  D. Barlow,et al.  The Lxl gene maps to mouse Chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters , 1996, Mammalian Genome.

[894]  Wooin Lee,et al.  A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. , 2007, Molecular endocrinology.

[895]  J. Unadkat,et al.  Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant Mouse , 2007, Drug Metabolism and Disposition.

[896]  C. Klaassen,et al.  Kupffer Cell-Mediated Downregulation of Hepatic Transporter Expression in Rat Hepatic Ischemia-Reperfusion , 2006, Transplantation.

[897]  W. Wahli,et al.  Regional variations in ABC transporter expression along the mouse intestinal tract. , 2004, Physiological genomics.

[898]  M. Zhou,et al.  Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylation , 2008, Neuroscience.

[899]  F. Baas,et al.  Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[900]  Y. Teo,et al.  Effect of MDR1 haplotype on risk of Parkinson disease. , 2005, Archives of neurology.

[901]  S. O. Mueller,et al.  Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. , 2009, Toxicology and applied pharmacology.

[902]  S. Adibi,et al.  Characterization of an oligopeptide transporter in renal lysosomes. , 2000, Biochimica et biophysica acta.

[903]  C. Andres,et al.  ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy , 2009, Journal of Medical Genetics.

[904]  M. Kasuga,et al.  MDR1 Genotype-Related Duodenal Absorption Rate of Digoxin in Healthy Japanese Subjects , 2003, Pharmaceutical Research.

[905]  T. Litman,et al.  Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2 , 2005, Journal of Cell Science.

[906]  R. Keep,et al.  Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. , 2004, Molecular pharmaceutics.

[907]  C. Ackerley,et al.  Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[908]  P. Meier,et al.  In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. , 1994, Gastroenterology.

[909]  H. Takane,et al.  Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin , 2006, Journal of Human Genetics.

[910]  V. Ganapathy,et al.  Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta* , 1998, The Journal of Biological Chemistry.

[911]  N. Ballatori,et al.  Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter* , 1998, The Journal of Biological Chemistry.

[912]  M. Chen,et al.  Increased sensitivity of , 1998 .

[913]  M. Wortham,et al.  Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver , 2007, Drug Metabolism and Disposition.

[914]  R. Hegele,et al.  ABCC6 gene polymorphism associated with variation in plasma lipoproteins , 2001, Journal of Human Genetics.

[915]  S. Nigam,et al.  Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. , 2004, American journal of physiology. Renal physiology.

[916]  D. Housman,et al.  Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells , 1990, Molecular and cellular biology.

[917]  J. Bene,et al.  Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients , 2007, Pathology & Oncology Research.

[918]  P. Honkakoski,et al.  Induction of drug metabolism by nuclear receptor CAR: molecular mechanisms and implications for drug research. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[919]  G. Amidon,et al.  Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine , 2009, Drug Metabolism and Disposition.

[920]  S. Glaser,et al.  Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. , 1997, Gastroenterology.

[921]  A. Bonci,et al.  The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference , 2004, Nature Neuroscience.

[922]  C. Cass,et al.  Role of Human Nucleoside Transporters in the Cellular Uptake of Two Inhibitors of IMP Dehydrogenase, Tiazofurin and Benzamide Riboside , 2005, Molecular Pharmacology.

[923]  P. Meier,et al.  Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells. , 1994, The American journal of physiology.

[924]  J. Wijnholds,et al.  Multidrug Resistance Protein 1 Protects the Oropharyngeal Mucosal Layer and the Testicular Tubules against Drug-induced Damage , 1998, The Journal of experimental medicine.

[925]  E. Hudson,et al.  The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). , 2000, Journal of cell science.

[926]  H. Rosing,et al.  Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics , 2006, Clinical Cancer Research.

[927]  Jaana Rysä,et al.  ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. , 2008, Toxicology and applied pharmacology.

[928]  J. Lippincott-Schwartz,et al.  Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes. , 2004, Molecular biology of the cell.

[929]  S. Lutsenko Atp7b-/- mice as a model for studies of Wilson's disease. , 2008, Biochemical Society transactions.

[930]  J. Nezu,et al.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.

[931]  Adam L VanWert,et al.  Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates , 2008, Pharmaceutical Research.

[932]  Xingguo Cheng,et al.  Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[933]  Y. Sugiyama,et al.  Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C). , 2004, Pharmacogenetics.

[934]  Y. Sugiyama,et al.  Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. , 2000, Pharmaceutical research.

[935]  S. Choudhuri,et al.  Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. , 2002, The Journal of pharmacology and experimental therapeutics.

[936]  Peter J. Meier,et al.  Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.

[937]  P. McNamara,et al.  Active transport of cimetidine into human milk , 1995, Clinical pharmacology and therapeutics.

[938]  G. Peters,et al.  Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines. , 1998, British Journal of Cancer.

[939]  P. A. Rea,et al.  Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. , 2001, Cancer research.

[940]  H. Takikawa,et al.  Effects of Organic Anions and Bile Acid Conjugates on Biliary Excretion of Pravastatin in the Rat , 2004, Pharmaceutical Research.

[941]  Yuichi Sugiyama,et al.  Involvement of Breast Cancer Resistance Protein (ABCG2) in the Biliary Excretion Mechanism of Fluoroquinolones , 2007, Drug Metabolism and Disposition.

[942]  M. Kasuga,et al.  Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. , 2002, Biological & pharmaceutical bulletin.

[943]  B. Giros,et al.  Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain , 2006, Neuropharmacology.

[944]  P. Meier,et al.  Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.

[945]  C. Hawkins,et al.  Expression patterns of the organic cation/carnitine transporter family in adult murine brain , 2008, Brain and Development.

[946]  Thomas Ludwig,et al.  Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. , 2004, Kidney international.

[947]  Jeffrey S Moffit,et al.  Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.

[948]  Zhe-Sheng Chen,et al.  Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). , 2003, Molecular pharmacology.

[949]  P. Borst,et al.  Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene , 2005, Hepatology.

[950]  A. Enomoto,et al.  Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.

[951]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[952]  A. Takeuchi,et al.  Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. , 2003, Drug metabolism and pharmacokinetics.

[953]  J. Watchko,et al.  ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS , 2008, Neuropediatrics.

[954]  L. Braiterman,et al.  NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[955]  T. Abe,et al.  Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina. , 2002, Investigative ophthalmology & visual science.

[956]  E. Burchard,et al.  Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) , 2006, Molecular Pharmacology.

[957]  K. Inui,et al.  Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). , 2008, Biochemical pharmacology.

[958]  S. Nigam,et al.  Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. , 2004, Biochemical and biophysical research communications.

[959]  E. Babu,et al.  Human organic anion transporters mediate the transport of tetracycline. , 2002, Japanese journal of pharmacology.

[960]  W. Müller,et al.  Cholesterol: Coupling between membrane microenvironment and ABC transporter activity. , 2007, Biochemical and biophysical research communications.

[961]  Y. Cheung,et al.  Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression. , 2005, British journal of clinical pharmacology.

[962]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). , 1998, FEBS letters.

[963]  P. Wielinga,et al.  Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). , 2003, The Biochemical journal.

[964]  Brian Tomlinson,et al.  OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine , 2008, Pharmacogenetics and genomics.

[965]  D. Häussinger,et al.  Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[966]  T. Ishikawa,et al.  Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. , 1986, The Journal of biological chemistry.

[967]  A. Hofman,et al.  Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus , 2009, The Pharmacogenomics Journal.

[968]  Zhe-Sheng Chen,et al.  Transport of Bile Acids, Sulfated Steroids, Estradiol 17-β-d-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11) , 2005, Molecular Pharmacology.

[969]  Y. Sugiyama,et al.  Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3 , 2004, Pharmaceutical Research.

[970]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[971]  H. Kusuhara,et al.  Human Organic Anion Transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conjugate , 2007, Drug Metabolism and Disposition.

[972]  Michael Böhm,et al.  Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart , 2006, Clinical pharmacology and therapeutics.

[973]  J. Hayashi,et al.  In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[974]  C. Klaassen,et al.  Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[975]  G. Tsujimoto,et al.  Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter , 1999, Nature Genetics.

[976]  T. Ishikawa,et al.  In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. , 2007, Drug metabolism and pharmacokinetics.

[977]  J. Ware,et al.  Breast Cancer Resistance Protein (BCRP/ABCG2) is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse , 2006, Molecular pharmaceutics.

[978]  F. Bredin,et al.  Evidence for association of OCTN genes and IBD5 with ulcerative colitis , 2005, Gut.

[979]  D. Roden,et al.  The Organic Cation Transporter, OCTN1, Expressed in the Human Heart, Potentiates Antagonism of the HERG Potassium Channel , 2009, Journal of cardiovascular pharmacology.

[980]  M. Anwer,et al.  PKCζ Is Required for Microtubule‐Based Motility of Vesicles Containing the ntcp Transporter , 2006, Traffic.

[981]  J. Kigawa,et al.  Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. , 2001, The Journal of pharmacology and experimental therapeutics.

[982]  K. To,et al.  Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells , 2003, Pflügers Archiv.

[983]  P. Kaufmann,et al.  Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). , 2004, Pharmacogenetics.

[984]  Nashville Tennessee,et al.  Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2) , 2005, Journal of Biological Chemistry.

[985]  S. Choudhuri,et al.  Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[986]  J. Keelan,et al.  Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. , 2007, Placenta.

[987]  D. Häussinger,et al.  Protein kinase C–dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells , 2001, Hepatology.

[988]  H. Takanaga,et al.  Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier , 2004, Journal of Pharmacology and Experimental Therapeutics.

[989]  D. Umbenhauer,et al.  The subpopulation of CF‐1 mice deficient in P‐glycoprotein contains a murine retroviral insertion in the mdr1a gene , 2001, Journal of biochemical and molecular toxicology.

[990]  Hiroshi Omote,et al.  A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[991]  D. Häussinger,et al.  Degradation of the sodium taurocholate cotransporting polypeptide (NTCP) by the ubiquitin-proteasome system , 2005, Biological chemistry.

[992]  Yuichi Sugiyama,et al.  Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. , 2007, Journal of the American Society of Nephrology : JASN.

[993]  R. Hyde,et al.  Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)* , 2001, The Journal of Biological Chemistry.

[994]  D. Häussinger,et al.  Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. , 1999, Gastroenterology.

[995]  Shuzhong Zhang,et al.  Organic cation transporters are determinants of oxaliplatin cytotoxicity. , 2006, Cancer research.

[996]  K. Hillgren,et al.  Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. , 2008, Molecular pharmaceutics.

[997]  C. Klaassen,et al.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[998]  Min Goo Lee,et al.  Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells. , 2002, Gastroenterology.

[999]  Xingguo Cheng,et al.  Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. , 2006, Biochemical pharmacology.

[1000]  P. McNamara,et al.  N-(4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine Carboxamide (GF120918) As a Chemical ATP-Binding Cassette Transporter Family G Member 2 (Abcg2) Knockout Model to Study Nitrofurantoin Transfer into Milk , 2008, Drug Metabolism and Disposition.

[1001]  F. Sirotnak,et al.  Molecular cloning of the murine cMOAT ATPase. , 2000, Biochimica et biophysica acta.

[1002]  D. Keppler,et al.  Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1003]  M. Willingham,et al.  Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[1004]  T. Fujita,et al.  What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. , 2006, Drug metabolism and pharmacokinetics.

[1005]  J. Nezu,et al.  Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.

[1006]  K. Maeda,et al.  Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin , 2005, Journal of Pharmacology and Experimental Therapeutics.

[1007]  C. Ko,et al.  Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[1008]  H. Chen,et al.  Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[1009]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[1010]  J. Wijnholds,et al.  MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.

[1011]  Y. Kato,et al.  Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. , 2004, Journal of pharmaceutical sciences.

[1012]  T. Dale,et al.  Contribution of the ABC Transporters Bcrp1 and Mdr1a/1b to the Side Population Phenotype in Mammary Gland and Bone Marrow of Mice , 2005, Stem cells.

[1013]  J. Boyer,et al.  Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.

[1014]  S. Yao,et al.  Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[1015]  M. Makishima,et al.  Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.

[1016]  K. Wirtz,et al.  The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice , 1994, FEBS letters.

[1017]  R. Kim,et al.  Identification of functionally variant MDR1 alleles among European Americans and African Americans , 2001, Clinical pharmacology and therapeutics.

[1018]  J. Boyer,et al.  The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver. , 2007, Toxicology and applied pharmacology.

[1019]  M. Zegers,et al.  Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells. , 1998, The Biochemical journal.

[1020]  G. Mitchell,et al.  L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. , 2004, American journal of physiology. Cell physiology.

[1021]  G. Burckhardt,et al.  Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. , 2004, American journal of physiology. Renal physiology.

[1022]  K. Brouwer,et al.  Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[1023]  F. Sharom,et al.  P‐Glycoprotein is localized in intermediate‐density membrane microdomains distinct from classical lipid rafts and caveolar domains , 2005, The FEBS journal.

[1024]  S. Cole,et al.  Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1). , 2003, Biochemistry.

[1025]  Lieke M van der Velden,et al.  ATP8B1 is essential for maintaining normal hearing , 2009, Proceedings of the National Academy of Sciences.

[1026]  Anand K. Srivastava,et al.  Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption , 2001, Nature Genetics.

[1027]  D. Keppler,et al.  Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain , 2004, Neuroscience.

[1028]  C. Cass,et al.  Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system , 2001, Neuropharmacology.

[1029]  K. Giacomini,et al.  Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system. , 1999, The Journal of pharmacology and experimental therapeutics.

[1030]  C. Paulusma,et al.  Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. , 2008, Gastroenterology.

[1031]  H. Endou,et al.  Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. , 2002, Molecular pharmacology.

[1032]  C. Garrovo,et al.  St John's wort modulation and developmental expression of multidrug transporters in the rat , 2006, Phytotherapy research : PTR.

[1033]  Y. Sawada,et al.  Kinetic Analysis of P-Glycoprotein-Mediated Transport by Using Normal Human Placental Brush-Border Membrane Vesicles , 2004, Pharmaceutical Research.

[1034]  L. Varticovski,et al.  Phosphoinositide 3-kinase lipid products regulate ATP-dependent transport by sister of P-glycoprotein and multidrug resistance associated protein 2 in bile canalicular membrane vesicles. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1035]  Maristela L Onozato,et al.  Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.

[1036]  V. Ganapathy,et al.  Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 (*) , 1995, The Journal of Biological Chemistry.

[1037]  Fanfan Zhou,et al.  Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[1038]  P. Kurki [Cyclosporin treatment]. , 1992, Duodecim; laaketieteellinen aikakauskirja.

[1039]  Jing Li,et al.  Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients , 2007, Cancer biology & therapy.

[1040]  C. Klaassen Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate after microsomal enzyme induction. , 1970, Biochemical pharmacology.

[1041]  J. Boyer,et al.  Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. , 2004, Journal of hepatology.

[1042]  G. Scheffer,et al.  Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[1043]  K. Faber,et al.  ATP binding cassette transporter gene expression in rat liver progenitor cells , 2003, Gut.

[1044]  M. Gottesman,et al.  Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. , 2002, Molecular pharmacology.

[1045]  H. Koepsell,et al.  Regulation of the human organic cation transporter hOCT1 , 2004, Journal of cellular physiology.

[1046]  H. Kusuhara,et al.  Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. , 2007, Molecular pharmacology.

[1047]  Xingguo Cheng,et al.  Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. , 2004, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[1048]  G. Hooiveld,et al.  Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .

[1049]  H. Koepsell,et al.  Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent , 2009, Cellular and Molecular Life Sciences.

[1050]  P. Meier,et al.  Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.

[1051]  U. Hofmann,et al.  DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR– RATS , 2005, Drug Metabolism and Disposition.

[1052]  W. Duan,et al.  Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.

[1053]  P. Bosma,et al.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[1054]  Y. Kato,et al.  Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2. , 2006, Drug metabolism and pharmacokinetics.

[1055]  Y. Kanai,et al.  Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.

[1056]  U. Hofmann,et al.  MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. , 2002, British journal of clinical pharmacology.

[1057]  D. Beier,et al.  Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. , 1996, Gastroenterology.

[1058]  Y. Sugiyama,et al.  Biliary Excretion of 17β-Estradiol 17β-d-Glucuronide Is Predominantly Mediated by cMOAT/MRP2 , 2000, Pharmaceutical Research.

[1059]  E. Mayatepek,et al.  Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency , 2000, Human mutation.

[1060]  T. Schmid,et al.  Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. , 2000, The Biochemical journal.

[1061]  J. Turner,et al.  Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[1062]  J. Nezu,et al.  Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane , 2003, Journal of Pharmacology and Experimental Therapeutics.

[1063]  C. Shim,et al.  Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[1064]  Kei-ichi Minami,et al.  Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. , 2007, Biochemical pharmacology.

[1065]  C. Boyd,et al.  The Distribution of Abcc6 in Normal Mouse Tissues Suggests Multiple Functions for this ABC Transporter , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[1066]  C. Cass,et al.  Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells , 2005, Journal of neurochemistry.

[1067]  N. Freimer,et al.  A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis , 1998, Nature Genetics.

[1068]  D. Keppler,et al.  Detection of the Human Organic Anion Transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in Liver and Hepatocellular Carcinoma , 2003, Laboratory Investigation.

[1069]  S. Kliewer,et al.  FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption Published, JLR Papers in Press, September 6, 2007. , 2007, Journal of Lipid Research.

[1070]  C. Endres,et al.  The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes , 2009, Journal of Pharmacology and Experimental Therapeutics.

[1071]  Yong-Hae Han,et al.  Current industrial practices of assessing permeability and P-glycoprotein interaction , 2006, The AAPS Journal.

[1072]  K. Linton,et al.  Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.

[1073]  Hongbing Wang,et al.  Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. , 2003, Current drug metabolism.

[1074]  E. Wallace,et al.  Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. , 2004, Placenta.

[1075]  H. Kowarzyk Structure and Function. , 1910, Nature.

[1076]  M. Böhm,et al.  The ATP-binding Cassette Transporter ABCG2 (BCRP), a Marker for Side Population Stem Cells, Is Expressed in Human Heart , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[1077]  V. Ganapathy,et al.  Localization of peptide transporter in nuclei and lysosomes of the pancreas , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[1078]  Y. Sugiyama,et al.  Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[1079]  L. Malerød,et al.  Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. , 2005, Biochemical and biophysical research communications.

[1080]  K. Köhrer,et al.  Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[1081]  Y. Kato,et al.  Involvement of Multidrug Resistance-Associated Protein 2 (Abcc2) in Molecular Weight-Dependent Biliary Excretion of β-Lactam Antibiotics , 2008, Drug Metabolism and Disposition.

[1082]  V. Vollrath,et al.  Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. , 1996, Journal of hepatology.

[1083]  Masaki Kobayashi,et al.  Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. , 2006, Biochimica et biophysica acta.

[1084]  S. Bates,et al.  Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1) , 2002, Cancer biology & therapy.

[1085]  R. Béliveau,et al.  Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. , 1996, The American journal of physiology.

[1086]  J. Wess,et al.  Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse , 2007, Journal of Molecular Neuroscience.

[1087]  B. Blumberg,et al.  Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. , 2006, Cancer research.

[1088]  Richard J. Thompson,et al.  Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. , 1999, Gastroenterology.

[1089]  R. Angeletti,et al.  Interaction with PDZK1 Is Required for Expression of Organic Anion Transporting Protein 1A1 on the Hepatocyte Surface* , 2005, Journal of Biological Chemistry.

[1090]  M. Perassolo,et al.  Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. , 2004, Biochemical pharmacology.

[1091]  L. Pike Rafts defined: a report on the Keystone symposium on lipid rafts and cell function Published, JLR Papers in Press, April 27, 2006. , 2006, Journal of Lipid Research.

[1092]  Svetlana Lutsenko,et al.  Function and regulation of human copper-transporting ATPases. , 2007, Physiological reviews.

[1093]  L. Pawlikowska,et al.  Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport , 2006, Hepatology.

[1094]  H. Saito,et al.  Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2 , 2000, Pflügers Archiv.

[1095]  R. Ueda,et al.  MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer , 2008, Molecular Cancer Therapeutics.

[1096]  I. Arias,et al.  Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters , 2000, Seminars in liver disease.

[1097]  S. Cole,et al.  Multidrug Resistance Protein , 1998, The Journal of Biological Chemistry.

[1098]  Y. Sugiyama,et al.  Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3 , 2008, Pharmacogenetics and genomics.

[1099]  M. Makishima,et al.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.

[1100]  F. Lang,et al.  Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1* , 1996, The Journal of Biological Chemistry.

[1101]  K. Giacomini,et al.  Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. , 2006, Journal of pharmaceutical sciences.

[1102]  J. Mackey,et al.  Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. , 1999, Journal of the National Cancer Institute.

[1103]  T. van der Poll,et al.  Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis , 2002, Clinical and experimental immunology.

[1104]  G. Mickisch Multidrug Resistance , 1996, Der Urologe A.

[1105]  N. Grishin,et al.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. , 2000, Science.

[1106]  Y. Kanai,et al.  Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney. , 2000, Kidney international.

[1107]  R. Keep,et al.  Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[1108]  Masahiko Watanabe,et al.  Distinct spatio‐temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain , 2005, Journal of neurochemistry.

[1109]  P. Dawson,et al.  Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. , 1995, The Journal of clinical investigation.

[1110]  D. Beier,et al.  Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice* , 2002, The Journal of Biological Chemistry.

[1111]  W. R. Wikoff,et al.  Multiple organic anion transporters contribute to net renal excretion of uric acid. , 2008, Physiological genomics.

[1112]  F. Suchy,et al.  Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. , 1996, The American journal of physiology.

[1113]  T. Greiner,et al.  Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma , 2008, Molecular Cancer Therapeutics.

[1114]  H. Kusuhara,et al.  Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. , 2004, Drug metabolism and pharmacokinetics.

[1115]  Honggang Wang,et al.  Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence. , 2008, Biochemistry.

[1116]  Y. Kanai,et al.  Transport of ochratoxin A by renal multispecific organic anion transporter 1. , 1998, The Journal of pharmacology and experimental therapeutics.

[1117]  Naoyuki Kamatani,et al.  Genetic variations of the ABC transporter gene ABCB11 encoding the human bile salt export pump (BSEP) in a Japanese population. , 2009, Drug metabolism and pharmacokinetics.

[1118]  P. Meier,et al.  The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids , 2005, Molecular Pharmacology.

[1119]  P. Langguth,et al.  Caki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3 , 2008, Nephron Physiology.

[1120]  G. Reid,et al.  Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization. , 2003, Journal of the American Society of Nephrology : JASN.

[1121]  T. Kitano,et al.  Allele frequencies of a SNP and a 27-bp deletion that are the determinant of earwax type in the ABCC11 gene. , 2008, Legal medicine.

[1122]  Xingguo Cheng,et al.  REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.

[1123]  C. Klaassen,et al.  Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents , 2006, Peptides.

[1124]  A. Enomoto,et al.  Function and localization of urate transporter 1 in mouse kidney. , 2004, Journal of the American Society of Nephrology : JASN.

[1125]  O. Ogawa,et al.  Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. , 2006, Journal of the American Society of Nephrology : JASN.

[1126]  H. Koepsell,et al.  Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene , 2001, Molecular and Cellular Biology.

[1127]  J. Manautou,et al.  Influence of Acetaminophen Vehicle on Regulation of Transporter Gene Expression During Hepatotoxicity , 2007, Journal of toxicology and environmental health. Part A.

[1128]  M. Hidalgo,et al.  Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. , 2006, Journal of the National Cancer Institute.

[1129]  G R Wilkinson,et al.  OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[1130]  R. Ringseis,et al.  Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. , 2008, European journal of pharmacology.

[1131]  A. Fagan,et al.  P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.

[1132]  Atsushi Ose,et al.  Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds , 2008, Drug Metabolism and Disposition.

[1133]  H. Denk,et al.  Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[1134]  Zhe-Sheng Chen,et al.  MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenine* , 2003, Journal of Biological Chemistry.

[1135]  T. Abe,et al.  OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER , 2006, Drug Metabolism and Disposition.

[1136]  M. Kimura,et al.  Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats , 1998, Biochemistry and molecular biology international.

[1137]  Xingguo Cheng,et al.  Tissue Distribution, Ontogeny, and Hormonal Regulation of Xenobiotic Transporters in Mouse Kidneys , 2009, Drug Metabolism and Disposition.

[1138]  H. Rosing,et al.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1139]  D. Keppler,et al.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.

[1140]  Kelly A. Harmon,et al.  The Role of Efflux and Uptake Transporters in N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) Disposition and Drug Interactions , 2008, Drug Metabolism and Disposition.

[1141]  Ning Li,et al.  Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[1142]  C. Klaassen Effect of Microsomal Enzyme Inducers on the Biliary Excretion of an Exogenous Load of Bilirubin in Newborn Rats 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[1143]  C. Endres,et al.  The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(−/−) Mice , 2009, Journal of Pharmacology and Experimental Therapeutics.

[1144]  R. Keep,et al.  Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice , 2009, Journal of neurochemistry.

[1145]  A. S. Gross,et al.  The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. , 2008, British journal of clinical pharmacology.

[1146]  J. Schellens,et al.  Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2) , 2005, Cancer Chemotherapy and Pharmacology.

[1147]  H. Faulstich,et al.  Identification of phalloidin uptake systems of rat and human liver. , 2004, Biochimica et biophysica acta.

[1148]  Yoshinori Morita,et al.  MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects , 2001, Pharmaceutical Research.

[1149]  T. Ishikawa,et al.  Functional Validation of the Genetic Polymorphisms of Human ATP-Binding Cassette (ABC) Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport , 2006, Molecular Pharmacology.

[1150]  P. Meier,et al.  Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[1151]  Jonathan C. Cohen,et al.  ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500115-JLR200 , 2005, Journal of Lipid Research.

[1152]  J. Verweij,et al.  Interaction of Cisplatin with the Human Organic Cation Transporter 2 , 2008, Clinical Cancer Research.

[1153]  G. Burckhardt,et al.  Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux , 2003, Cellular Physiology and Biochemistry.

[1154]  G. Kullak-Ublick,et al.  The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α , 2006, Journal of Pharmacology and Experimental Therapeutics.

[1155]  E. G. de la Concha,et al.  Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. , 2006, The Journal of rheumatology.

[1156]  Russ B. Altman,et al.  PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..

[1157]  P. Meier,et al.  Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[1158]  W. Elmquist,et al.  Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux , 2003, Journal of Pharmacology and Experimental Therapeutics.

[1159]  V. Vollrath,et al.  Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. , 2006, The Biochemical journal.

[1160]  F. Russel,et al.  Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. , 2005, American journal of physiology. Renal physiology.

[1161]  R. Kim,et al.  Polymorphisms in OATP-C , 2001, The Journal of Biological Chemistry.

[1162]  H. Aburatani,et al.  Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. , 2003, Gene.

[1163]  S. Teng,et al.  Induction of ABCC3 (MRP3) by pregnane X receptor activators. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[1164]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[1165]  L Landmann,et al.  Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.

[1166]  I. Hisatome,et al.  Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans* , 2008, Journal of Biological Chemistry.

[1167]  T. Abe,et al.  Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. , 2001, The Journal of pharmacology and experimental therapeutics.

[1168]  B. Tuchweber,et al.  Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice. , 2003, Pharmacological research.

[1169]  M. Erion,et al.  Isolation of a family of organic anion transporters from human liver and kidney. , 2001, Biochemical and biophysical research communications.

[1170]  Rachel J. Johnson,et al.  Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[1171]  S. Barros,et al.  Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport* , 2009, Journal of Biological Chemistry.

[1172]  H. Friess,et al.  Gender‐specific expression of liver organic anion transporters in rat , 2005, European journal of clinical investigation.

[1173]  C. Enrich,et al.  Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway. , 2002, Experimental cell research.

[1174]  M. Pastor-Anglada,et al.  SLC28 genes and concentrative nucleoside transporter (CNT) proteins. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[1175]  G. Hooiveld,et al.  Up‐regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down‐regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver , 1998, Hepatology.

[1176]  D. Keppler,et al.  Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. , 1997, Journal of the American Society of Nephrology : JASN.

[1177]  Association of SLC22A4/5 Polymorphisms with Steroid Responsiveness of Inflammatory Bowel Disease in Japan , 2008, Diseases of the colon and rectum.

[1178]  G. Folkers,et al.  Identification of steroid sulfate transport processes in the human mammary gland. , 2003, The Journal of clinical endocrinology and metabolism.

[1179]  H. Endou,et al.  Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3 (rOAT3). , 2000, Life sciences.

[1180]  M. Vore,et al.  Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5′ Untranslated Region , 2007, Molecular Pharmacology.

[1181]  C. Klaassen,et al.  Xenobiotic transporters: ascribing function from gene knockout and mutation studies. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[1182]  F. Lang,et al.  Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1 , 1996, FEBS letters.

[1183]  G. Koren,et al.  Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta , 2008, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[1184]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[1185]  H. Daniel,et al.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology , 2004, Pflügers Archiv.

[1186]  J. Manautou,et al.  Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease , 2007, Toxicologic pathology.

[1187]  C. Klaassen,et al.  Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. , 2007, Biochimica et biophysica acta.

[1188]  A. Kastrati,et al.  Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential Hypertension , 2006, Clinical and experimental hypertension.

[1189]  T. Tanahashi,et al.  Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies , 2008, Journal of Human Genetics.

[1190]  Tohru Mizushima,et al.  NorM, a Putative Multidrug Efflux Protein, of Vibrio parahaemolyticus and Its Homolog in Escherichia coli , 1998, Antimicrobial Agents and Chemotherapy.

[1191]  H. Kusuhara,et al.  P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION , 2005, Drug Metabolism and Disposition.

[1192]  F. Russel,et al.  Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport , 2007, Journal of Pharmacology and Experimental Therapeutics.

[1193]  S. Masuda,et al.  Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer , 2008, Drug Metabolism and Disposition.

[1194]  A. Tall,et al.  ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.

[1195]  R. Evans,et al.  Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.

[1196]  S. Masuda,et al.  Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family) , 2006, Journal of Pharmacology and Experimental Therapeutics.

[1197]  K. Giacomini,et al.  Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. , 1997, The American journal of physiology.

[1198]  K. Giacomini,et al.  Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). , 2000, The Journal of pharmacology and experimental therapeutics.

[1199]  H. Endou,et al.  Differential gene expression of organic anion transporters in male and female rats. , 2002, Biochemical and biophysical research communications.

[1200]  G. Schmitz,et al.  ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? , 2000, Pathobiology.

[1201]  B. Sumegi,et al.  Phenotypic manifestations of the OCTN2 V295X mutation: Sudden infant death and carnitine‐responsive cardiomyopathy in Roma families , 2004, American journal of medical genetics. Part A.

[1202]  K. Hillgren,et al.  Comparison of human and monkey peptide transporters: PEPT1 and PEPT2. , 2004, Molecular pharmaceutics.

[1203]  Masahiko Watanabe,et al.  ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells , 2006, Pharmaceutical Research.

[1204]  E. Seidman,et al.  Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[1205]  R. Houwen,et al.  FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. , 2001, Journal of hepatology.

[1206]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[1207]  C. Klaassen,et al.  Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. , 2004, Biochemical and biophysical research communications.

[1208]  J. Nezu,et al.  Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1 , 1997, FEBS letters.

[1209]  Y. Kato,et al.  Involvement of Multidrug Resistance-Associated Protein 1 in Intestinal Toxicity of Methotrexate , 2009, Pharmaceutical Research.

[1210]  M. Finegold,et al.  Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. , 2006, The American journal of pathology.

[1211]  G R Lankas,et al.  Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. , 1997, Toxicology and applied pharmacology.

[1212]  D. Shen,et al.  MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents , 2009, Cancer Chemotherapy and Pharmacology.

[1213]  P. Meier,et al.  Functional analysis and androgen-regulated expression of mouse organic anion transporting polypeptide 1 (Oatp1) in the kidney. , 2001, Biochimica et biophysica acta.

[1214]  S. Ito,et al.  Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. , 2002, American journal of physiology. Renal physiology.

[1215]  F. Suchy,et al.  Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. , 1981, Gastroenterology.

[1216]  H. Daniel,et al.  Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. , 2002, American journal of physiology. Endocrinology and metabolism.

[1217]  C. Higgins,et al.  Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.

[1218]  Fanfan Zhou,et al.  The Role of N-Linked Glycosylation in Protein Folding, Membrane Targeting, and Substrate Binding of Human Organic Anion Transporter hOAT4 , 2005, Molecular Pharmacology.

[1219]  L. Chinn,et al.  ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise , 2007, Clinical pharmacology and therapeutics.

[1220]  Kaoru Kobayashi,et al.  Hepatocyte Nuclear Factor 1 Alpha is a Factor Responsible for the Interindividual Variation of OATP1B1 mRNA Levels in Adult Japanese Livers , 2007, Pharmaceutical Research.

[1221]  A. Taniguchi,et al.  A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. , 2005, Arthritis and rheumatism.

[1222]  A. Amoroso,et al.  Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. , 2003, Biochemical and biophysical research communications.

[1223]  J. Uitto,et al.  Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6-/-). , 2008, The Journal of investigative dermatology.

[1224]  J. Drewe,et al.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. , 2000, Molecular pharmacology.

[1225]  W. Gibb,et al.  Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. , 2008, Reproduction, fertility, and development.

[1226]  U. Völker,et al.  Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function , 2009, Pharmacogenetics and genomics.

[1227]  H. Daniel,et al.  Cellular and molecular mechanisms of renal peptide transport. , 1997, The American journal of physiology.

[1228]  M. L. Ruiz,et al.  Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose. , 2009, Biochemical Pharmacology.

[1229]  C. Klaassen,et al.  Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[1230]  H. Mohrenweiser,et al.  Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6) , 2005, Journal of Pharmacology and Experimental Therapeutics.

[1231]  R. O. Oude Elferink,et al.  Role of MRP2 and GSH in intrahepatic cycling of toxins. , 2001, Toxicology.

[1232]  I. Arias,et al.  Trafficking of canalicular ABC transporters in hepatocytes. , 2002, Annual review of physiology.

[1233]  S. Yao,et al.  Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs , 1997, Nature Medicine.

[1234]  R. Keep,et al.  Role of PEPT2 in the Choroid Plexus Uptake of Glycylsarcosine and 5-Aminolevulinic Acid: Studies in Wild-Type and Null Mice , 2004, Pharmaceutical Research.

[1235]  Yuichi Sugiyama,et al.  Polymorphisms of OATP‐C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics , 2003, Clinical pharmacology and therapeutics.

[1236]  Ya-li Liu,et al.  Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[1237]  S. Bandinelli,et al.  The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts , 2007, PLoS genetics.

[1238]  P. Meier,et al.  Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes. , 1990, The Journal of biological chemistry.

[1239]  T. Rikiyama,et al.  Farnesoid X receptor, hepatocyte nuclear factors 1α and 3β are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene , 2006, Journal of Gastroenterology.

[1240]  B. T. Hinton,et al.  Organic Cation/Carnitine Transporter, OCTN2, Is Differentially Expressed in the Adult Rat Epididymis1 , 2002 .

[1241]  M. P. Gallagher,et al.  Subcellular Distribution and Membrane Topology of the Mammalian Concentrative Na+-Nucleoside Cotransporter rCNT1* , 2001, The Journal of Biological Chemistry.

[1242]  Y. Kanai,et al.  Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. , 2004, Journal of pharmacological sciences.

[1243]  J. Nezu,et al.  Functional relevance of carnitine transporter OCTN2 to brain distribution of l‐carnitine and acetyl‐l‐carnitine across the blood–brain barrier , 2001, Journal of neurochemistry.

[1244]  Conrad C. Huang,et al.  Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1245]  H. Yawo,et al.  Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2) , 1999, FEBS letters.

[1246]  D. Keppler,et al.  Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.

[1247]  F. Döring,et al.  Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. , 1998, The Journal of clinical investigation.

[1248]  H. Saito,et al.  Gender differences in expression of organic cation transporter OCT2 in rat kidney , 1999, FEBS letters.

[1249]  M. Imamura,et al.  Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract. , 2005, Biochemical pharmacology.

[1250]  J. Mackey,et al.  Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. , 2007, American journal of physiology. Renal physiology.

[1251]  J. Whitlock,et al.  Induction of hepatic cytochrome P450 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1989, Molecular biology & medicine.

[1252]  K. Zatloukal,et al.  Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. , 2003, Journal of hepatology.

[1253]  D. Housman,et al.  mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. , 1992, The Journal of biological chemistry.

[1254]  J. Boyer,et al.  Down‐regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis , 2004, Hepatology.

[1255]  T. Cowan,et al.  A missense mutation in the OCTN2 gene associated with residual carnitine transport activity , 2000, Human mutation.

[1256]  V. Schuster,et al.  Identification and characterization of a prostaglandin transporter. , 1995, Science.

[1257]  P. Gros,et al.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.

[1258]  C. Klaassen,et al.  Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[1259]  Shigeki Sugiura,et al.  ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS , 2005, Drug Metabolism and Disposition.

[1260]  H. Kusuhara,et al.  Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. , 2002, Life sciences.

[1261]  V. Ganapathy,et al.  Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice. , 2007, Molecular genetics and metabolism.

[1262]  W. R. Wikoff,et al.  Organic anion transporter 3 contributes to the regulation of blood pressure. , 2008, Journal of the American Society of Nephrology : JASN.

[1263]  Christian Funck-Brentano,et al.  Digoxin pharmacokinetics and MDR1 genetic polymorphisms , 2003, European Journal of Clinical Pharmacology.

[1264]  K. Takata,et al.  Peptide Transporter in the Rat Small Intestine: Ultrastructural Localization and the Effect of Starvation and Administration of Amino Acids , 1999, The Histochemical Journal.

[1265]  P. Neuvonen,et al.  Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans , 2009, Pharmacogenetics and genomics.

[1266]  H. Takikawa,et al.  ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.

[1267]  B. Giros,et al.  Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation , 2004, The Journal of Neuroscience.

[1268]  H. Koepsell,et al.  The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. , 2000, Journal of the American Society of Nephrology : JASN.

[1269]  I. Rubio-Aliaga,et al.  Peptide transporters and their roles in physiological processes and drug disposition. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[1270]  K. Griffin,et al.  Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1271]  F. Lammert,et al.  Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.

[1272]  K. Nakayama,et al.  Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. , 2003, Biochemical pharmacology.

[1273]  A. Barton,et al.  Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. , 2005, Arthritis and rheumatism.

[1274]  W. Stremmel,et al.  Localization of the Wilson disease protein in murine intestine , 2008, Journal of anatomy.

[1275]  A. Coop,et al.  Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. , 2007, Journal of pharmaceutical sciences.

[1276]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .

[1277]  J. Unadkat,et al.  The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse – An OPRU Network and UW SCOR Study , 2007 .

[1278]  K. P. Brady,et al.  A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. , 1999, Genomics.

[1279]  C. Klaassen,et al.  Prominent Expression of Xenobiotic Efflux Transporters in Mouse Extraembryonic Fetal Membranes Compared with Placenta , 2008, Drug Metabolism and Disposition.

[1280]  F. Suchy,et al.  Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate , 1998, Hepatology.

[1281]  M. Devoto,et al.  Variants of OCTN1–2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.

[1282]  A. Lumsden,et al.  A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum , 2001, Journal of Molecular Medicine.